WO2011067272A1 - Insecticidal compounds based on isoxazoline derivatives - Google Patents
Insecticidal compounds based on isoxazoline derivatives Download PDFInfo
- Publication number
- WO2011067272A1 WO2011067272A1 PCT/EP2010/068605 EP2010068605W WO2011067272A1 WO 2011067272 A1 WO2011067272 A1 WO 2011067272A1 EP 2010068605 W EP2010068605 W EP 2010068605W WO 2011067272 A1 WO2011067272 A1 WO 2011067272A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methyl
- compound
- phenyl
- alkyl
- formula
- Prior art date
Links
- WSXXQPXCNMVEEI-UHFFFAOYSA-N BrC(c(cc1)c2ncccc2c1Br)Br Chemical compound BrC(c(cc1)c2ncccc2c1Br)Br WSXXQPXCNMVEEI-UHFFFAOYSA-N 0.000 description 1
- 0 C*(*)C(C(O)=**=C(C1=*OC(C)(*)C1)[U]=*)=N Chemical compound C*(*)C(C(O)=**=C(C1=*OC(C)(*)C1)[U]=*)=N 0.000 description 1
- QSZSBFIOTUHZKI-UHFFFAOYSA-N CC(C)(C)OC(NC1CSSC1)=O Chemical compound CC(C)(C)OC(NC1CSSC1)=O QSZSBFIOTUHZKI-UHFFFAOYSA-N 0.000 description 1
- HFSXCESFVWFTCT-UHFFFAOYSA-N CC(C)(C)OC(NCC(C1)ONC1=O)=O Chemical compound CC(C)(C)OC(NCC(C1)ONC1=O)=O HFSXCESFVWFTCT-UHFFFAOYSA-N 0.000 description 1
- BCEOWQGRCRLUOA-XLYVWGIVSA-N CCN(C1=O)OC[C@H]1NC(c(c(C)c1)ccc1C(/C=C(\C(F)(F)F)/c1cc(Cl)cc(Cl)c1)=O)=O Chemical compound CCN(C1=O)OC[C@H]1NC(c(c(C)c1)ccc1C(/C=C(\C(F)(F)F)/c1cc(Cl)cc(Cl)c1)=O)=O BCEOWQGRCRLUOA-XLYVWGIVSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Definitions
- the present invention relates to certain benzamide isoxazolines, to processes and intermediates for preparing them, to insecticidal, acaricidal, nematicidal and moUuscicidal compositions comprising them and to methods of using them to combat and control insect, acarine, nematode and mollusc pests.
- the present invention therefore provides a compound of formula (I):
- a 1 , A 2 , A 3 and A 4 are independently of one another C-H, C-R 5 , or nitrogen;
- G 1 is oxygen or sulfur
- L is a single bond or Ci-C 8 alkylene
- R 1 is hydrogen, Ci-C 8 alkyl, Ci-C 8 alkylcarbonyl-, Ci-C 8 alkoxy, Ci-C 8 alkoxy-Ci-C 8 alkyl,or Ci-Csalkoxycarbonyl-;
- R 2 is hydrogen, Ci-C 8 haloalkyl or Ci-C 8 alkyl
- R 3 is Ci-Cghaloalkyl
- R 4 is aryl or aryl substituted by one to three R 6 , or R 4 is heterocyclyl or heterocyclyl substituted by one to three R 6 ;
- each R 5 is independently halogen, cyano, nitro, Ci-C 8 alkyl, C 3 -C 8 cycloalkyl, Ci-C 8 haloalkyl, C 2 -C 8 alkenyl, C 2 -C 8 haloalkenyl, C 2 -C 8 alkynyl, C 2 -C 8 haloalkynyl, Ci-C 8 alkoxy,
- each R 6 is independently halogen, cyano, nitro, Ci-C 8 alkyl, Ci-C 8 haloalkyl, Ci-C 8 alkoxy, or Ci-C 8 haloalkoxy;
- each R 7 and R 8 is independently hydrogen, halogen, Ci-Csalkyl, or Ci-Cshaloalkyl;
- each R 9 is independently hydrogen, cyano, cyano-Ci-C 8 alkyl, Ci-C 8 alkyl, Ci-C 8 haloalkyl, C 3 -C 8 cycloalkyl, C 3 -C 8 cycloalkyl where one carbon atom is replaced by O, S, S(O) or S0 2 , or C 3 -C 8 cycloalkyl-Ci-Csalkyl, where one carbon atom in the cycloalkyl group is replaced by O, S, S(O) or S0 2 , or C 3 -C 8 Cycloalkyl-Ci-C 8 haloalkyl, Ci- Cshydroxyalkyl, Ci-Csalkoxy-Ci-Csalkyl, C 2 -Csalkenyl, C 2 -Cshaloalkenyl, C 2 -Csalkynyl, Q-Cshaloalkynyl, phenyl, phenyl substituted
- each R 10 is independently halogen, cyano, nitro, Ci-C 8 alkyl, Ci-C 8 haloalkyl, Ci-C 8 alkoxy, or Ci-Cshaloalkoxy;
- the compounds of formula (I) may exist in different geometric or optical isomers or tautomeric forms. This invention covers all such isomers and tautomers and mixtures thereof in all proportions as well as isotopic forms such as deuterated compounds.
- the compounds of the invention may contain one or more asymmetric carbon atoms, for example, in the -CR 3 R 4 - group or at the LR 2 Y J Y 4 carbon and may exist as enantiomers (or as pairs of diastereoisomers) or as mixtures of such. Further, where any Y group is SO, the compounds of the invention are sulfoxides, which can also exist in two enantiomeric forms.
- Each alkyl moiety either alone or as part of a larger group is a straight or branched chain and is, for example, methyl, ethyl, n-propyl, prop-2-yl, n-butyl, but-2-yl, 2-methyl-prop-l-yl or 2 -methyl -prop-2- yl.
- the alkyl groups are preferably Ci-C 6 alkyl groups, more preferably Ci-C 4 and most preferably Ci-C 3 alkyl groups.
- Alkenyl moieties can be in the form of straight or branched chains, and the alkenyl moieties, where appropriate, can be of either the (E)- or (Z)-configuration. Examples are vinyl and allyl.
- the alkenyl groups are preferably C 2 -C 6 , more preferably C 2 -C 4 and most preferably C 2 -C 3 alkenyl groups.
- Alkynyl moieties can be in the form of straight or branched chains. Examples are ethynyl and propargyl.
- the alkynyl groups are preferably C2-C6, more preferably C2-C4 and most preferably C2-C3 alkynyl groups.
- Halogen is fluorine, chlorine, bromine or iodine.
- Haloalkyl groups are alkyl groups which are substituted by one or more of the same or different halogen atoms and are, for example, trifluoromethyl, chlorodifluoromethyl, 2,2,2-trifluoro-ethyl or 2,2- difluoro-ethyl.
- Haloalkenyl groups are alkenyl groups, respectively, which are substituted with one or more of the same or different halogen atoms and are, for example, 2,2-difluorovinyl or 1 ,2-dichloro-2-fluoro-vinyl.
- Haloalkynyl groups are alkynyl groups, respectively, which are substituted with one or more of the same or different halogen atoms and are, for example, l-chloro-prop-2-ynyl.
- aryl refers to a ring system which may be mono-, bi- or tricyclic. Examples of such rings include phenyl, naphthalenyl, anthracenyl, indenyl or phenanthrenyl. A preferred aryl group is phenyl.
- heteroaryl refers to an aromatic ring system containing at least one heteroatom and consisting either of a single ring or of two or more fused rings.
- single rings will contain up to three heteroatoms and bicyclic systems up to four heteroatoms which will preferably be chosen from nitrogen, oxygen and sulfur.
- Examples of (5-6 membered) monocyclic groups include pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl, tetrazolyl, furanyl, thiophenyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, isothiazolyl, and thiadiazolyl.
- Examples of bicyclic groups include quinolinyl, cinnolinyl, quinoxalinyl, benzimidazolyl, benzothiophenyl, and
- Monocyclic heteroaryl groups are preferred, preferably monocyclic rings containing 1 to 3 heterotoms selected from O, N or S, e.g. pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, pyrazolyl, furanyl, thiophenyl, oxazolyl, isoxazolyl, thiazolyl, preferably pyridyl, pyrazolyl, furanyl, thiophenyl, thiazolyl, pyridyl being most preferred.
- heterocyclyl is defined to include heteroaryl and in addition their unsaturated or partially unsaturated analogues.
- Preferred values of A 1 , A 2 , A 3 , A 4 , G 1 , L, R 1 , R 2 , R 3 , R 4 , Y 1 , Y 2 , Y 3 , Y 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are, in any combination, as set out below.
- a 1 , A 2 , A 3 and A 4 are nitrogen.
- a 1 is C-H or C-R 5 , most preferably A 1 is C-R 5 .
- a 2 is C-H or C-R 5 , most preferably A 2 is C-H.
- a 3 is C-H or N, most preferably A 3 is C-H.
- a 4 is C-H or N, most preferably A 4 is C-H.
- G 1 is oxygen
- L is a single bond or Ci-C 4 alkylene. More preferably L is a single bond or CH 2 , most preferably a single bond.
- R 1 is hydrogen, methyl, ethyl, methylcarbonyl-, or methoxycarbonyl-, more preferably hydrogen, methyl or ethyl, even more preferably hydrogen or methyl, most preferably hydrogen.
- R 2 is hydrogen or methyl, most preferably hydrogen.
- R 3 is chlorodifluoromethyl or trifluoromethyl, most preferably trifluoro- methyl.
- R 4 is aryl or aryl substituted by one to three R 6 , more preferably R 4 is phenyl or phenyl substituted by one to three R 6 , even more preferably R 4 is phenyl substituted by one to three R 6 , more preferably R 4 is 3,5-bis-(trifluoromethyl)-phenyl, 3- chloro-5-trifluoromethyl-phenyl, 3-bromo-5-trifluoromethyl-phenyl, 3,5-dibromo-phenyl, 3,5-dichloro-phenyl, 3,4-dichloro-phenyl, 3-trifluoromethyl-phenyl, 4-bromo-3,5- dichlorophenyl, 4-fluoro-3,5-dichlorophenyl or 3,4,5-trichloro-phenyl, yet even more preferably R 4 is 3,5-dibromo-phenyl, 3,5-dichloro-phenyl, 3,5-bis-(trifluoromethyl)-phen
- each R 6 is independently bromo, chloro, fluoro, cyano, nitro, methyl, ethyl, trifluoromethyl, methoxy, difluoromethoxy, trifluoromethoxy, more preferably chloro, fluoro, cyano, nitro, methyl, ethyl, trifluoromethyl, methoxy, or trifluoromethoxy, most preferably bromo, chloro, or trifluoromethyl.
- Y 1 is CR 7 R 8 .
- two of Y , Y and Y in the grouping -Y -Y -Y - together are -S-S-, -S-SO-, -SO-SO-, -SO-SO2-, -SO2-SO2-, -0-N(-R 9 )-, -0-S-, -O-SO-, -O-SO2-, -N(-R 9 )-N(-R 9 )-, -N(-R 9 )-S-, -N(-R 9 )-S(0)-, or -N(-R 9 )-S0 2 -, more preferably -S-S-, -0-N(-R 9 )-, -0-SO-, -N(-R 9 )-N(-R 9 )-, -N(-R 9 )-S, -N(-R 9 )-S(0)- or -N(-R 9 )-S0 2 .
- the grouping -Y 2 -Y 3 -Y 4 - may be selected from -C(R 7 )(R 8 )-N(-R 9 )-N(-R 9 )-,
- the grouping -Y 2 -Y 3 -Y 4 - is selected from -C(R 7 )(R 8 )-N(-R 9 )-N(-R 9 )-, -C(R 7 )(R 8 )-N(-R 9 )-0-, -C(R 7 )(R 8 )-N(-R 9 )-S-, -C(R 7 )(R 8 )-N(-R 9 )-S0 2 -,
- -S0 2 -N(-R 9 )-N(-R 9 )-, -S0 2 -N(-R 9 )-0- and -S0 2 -0-C(R 7 )(R 8 )-. More preferably the grouping -Y 2 -Y 3 -Y 4 - is selected from -0-N(-R 9 )-C( 0)-, -S-S-C(R 7 )(R 8 )-,
- the grouping -Y 2 -Y 3 -Y 4 - is preferably selected from -C(R 7 )(R 8 )-N(-R 9 )-N(-R 9 )-,
- -SO-0-C(R 7 )(R 8 )-, -S0 2 -N(-R 9 )-C(R 7 )(R 8 )-, and -S0 2 -0-C(R 7 )(R 8 )-. More preferably the grouping -Y 2 -Y 3 -Y 4 - is selected from -S-S-C(R 7 )(R 8 )-, -0-N(-R 9 )-C( 0)-,
- Y 2 or Y 4 is CR 7 R 8 .
- the grouping _Y 2 -Y 3 -Y 4 - is preferably selected from -C(R 7 )(R 8 )-N(-R 9 )-N(-R 9 )-, -C(R 7 )(R 8 )-N(-R 9 )-0-, -C(R 7 )(R 8 )-N(-R 9 )-S-, -C(R 7 )(R 8 )-N(-R 9 )-S0 2 -, -C(R 7 )(R 8 )-0-N(-R 9 )-, -C(R 7 )(R 8 )-0-SO-, -C(R 7 )(R 8 )-0-S0 2 -, -C(R 7 )(R 8 )-S-N(-R 9 )-, -C(R 7 )(R 8 )-S-N(-
- Y 2 -Y 3 -Y 4 - is selected from -S-S-C(R 7 )(R 8 )-,
- Y 2 and Y 4 are independently N-R 9 , O, S, SO or S0 2 . According to this embodiement the grouping -Y 2 -Y 3 -Y 4 - is preferably selected from
- Y 2 -Y 3 -Y 4 - is selected from-N(-R 9 )-S0 2 -0-, -0-S0 2 -0-,
- Y 2 and Y 3 are
- Y 2 and Y 3 are independently N-R 9 , O or S.
- Y 2 is O or S. More preferably Y 2 is O.
- Y 3 is N-R 9 .
- Y 1 is CR 7 R 8
- Y 1 is CR 7 R 8
- Y 2 is N-R 9 , O, S, SO or S0 2
- Y 3 is N-R 9
- Y 1 is CR 7 R 8
- Y 2 is O or S
- Y 3 is N-R 9
- Y 1 is CR 7 R 8
- Y 2 is N-R 9
- Y 3 is O or S
- L is Ci-C 4 alkylene.
- Y 4 is NR 9
- L is Ci-C 4 alkylene
- Y 3 is preferably NR 9 , O, S, SO or S0 2 .
- L is Ci-C 4 alkylene, in which case Y 3 is preferably NR 9 .
- At least two adjacent ring atoms in the ring formed by Y 1 , Y 2 , Y 3 and Y 4 are heteroatoms.
- the ring formed by Y 1 , Y 2 , Y 3 and Y 4 does not contain two adjacent oxygen atoms. In some cases there may be no more than one oxygen ring atom in the ring formed by Y 1 , Y 2 , Y 3 and Y 4 .
- Embodiments providing Y 1 , Y 2 , Y 3 , Y 4 values may be combined with any of the values, including preferred values, of A 1 , A 2 , A 3 , A 4 , G 1 , L, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 .
- each R 7 is independently hydrogen, or Ci-C 8 alkyl, most preferably hydrogen.
- each R 8 is independently hydrogen, or Ci-C 8 alkyl, most preferably hydrogen.
- R 7 and R 8 are both hydrogen.
- each R 9 is independently hydrogen, cyano-Ci-C 8 alkyl, Ci-C 8 alkyl, C 3 - C 8 cycloalkyl, C 3 -C 8 cycloalkyl where one carbon atom in the cycloalkyl group is replaced by O, S, S(O) or S0 2 , or C 3 -C 8 cycloalkyl-Ci-C 8 alkyl, C 3 -C 8 cycloalkyl-Ci-C 8 alkyl where one carbon atom in the cycloalkyl group is replaced by O, S, S(O) or S0 2 , or Ci-C 8 haloalkyl, Ci- C 8 hydroxyalkyl, Ci-C 8 hydroxyalkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, phenyl-Ci-C 4 alkyl or phenyl-Ci-C 4 alkyl wherein the phenyl moiety is substitute
- Ci-Cshaloalkyl Ci-Cshydroxyalkyl, C 2 -Csalkenyl, C 2 -Csalkynyl, phenyl-Ci-C 4 alkyl or phenyl-Ci-C 4 alkyl wherein the phenyl moiety is substituted by one to three R 10 , 5-6 membered heteroaryl-Ci-C 4 alkyl or 5-6 membered heteroaryl-Ci-C 4 alkyl wherein the heteroaryl moiety is substituted by one to three R 10 ; even more preferably each R 9 is independently hydrogen, cyano-Ci-C 6 alkyl, Ci-C 6 alkyl, C 3 -C 6 cycloalkyl, C 3 -C 6 cycloalkyl where one carbon atom in the cycloalkyl group is replaced by O, S, S(O) or S0 2 , or Ci- C 6 haloalkyl, Ci-C 6 hydroxyalkyl, Ci-
- Heteroaryl preferably refers to pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, pyrazolyl, furanyl, thiophenyl, oxazolyl, isoxazolyl or thiazolyl, more preferably pyridyl, pyrazolyl, furanyl, thiophenyl or thiazolyl, most preferably pyridyl.
- each R 10 is independently halogen, cyano, Ci-Cshaloalkyl, Ci-Csalkoxy or Ci-Cshaloalkoxy, most preferably, fluoro, chloro, bromo, trifluoromethyl, trifluoromethoxy, cyano or methoxy.
- a 1 , A 2 , A 3 and A 4 are independently of one another C-H, C-R 5 , or nitrogen;
- G 1 is oxygen or sulfur
- L is a single bond or Ci-C 8 alkylene
- R 1 is hydrogen, Ci-Csalkyl, Ci-Csalkylcarbonyl-, or Ci-Csalkoxycarbonyl-;
- R 2 is hydrogen, or Ci-Csalkyl
- R 3 is Ci-C 8 haloalkyl
- R 4 is aryl, aryl substituted by one to three R 6 , or R 4 is heterocyclyl, or heterocyclyl substituted by one to three R 6 ;
- each R 6 is independently halogen, cyano, nitro, Ci-C 8 alkyl, Ci-C 8 haloalkyl, Ci-C 8 alkoxy, or Ci-Cshaloalkoxy;
- each R 7 and R 8 is independently hydrogen, halogen, Ci-C 8 alkyl, or Ci-C 8 haloalkyl;
- each R 9 is independently hydrogen, cyano, cyano-Ci-C 8 alkyl, Ci-C 8 alkyl, Ci-C 8 haloalkyl, C 3 -C 8 cycloalkyl, C 3 -C 8 cycloalkyl where one carbon atom is replaced by O, S, S(O) or S0 2 , C 3 -C 8 cycloalkyl-Ci-C 8 alkyl, C 3 -C 8 cycloalkyl-Ci-C 8 alkyl where one carbon atom in the cycloalkyl group is replaced by O, S, S(O) or S0 2 , C 3 -C 8 cycloalkyl-Ci-C 8 haloalkyl,
- each R 10 is independently halogen, cyano, nitro, Ci-C 8 alkyl, Ci-C 8 haloalkyl, Ci-C 8 alkoxy, or Ci-C 8 haloalkoxy, or a salt of N-oxide thereof.
- each R 9 is preferably independently hydrogen, cyano-Ci- C 8 cycloalkyl, C 3 -C 8 cycloalkyl-Ci-C 8 alkyl, Ci-C 8 haloalkyl, Ci-C 8 hydroxyalkyl, Ci- C 8 alkoxyalkyl, C 2 -Csalkenyl, C 2 -Csalkynyl, phenyl-Ci-C 4 alkyl or phenyl-Ci-C 4 alkyl wherein the phenyl moiety is substituted by one to three R 10 , or each R 9 is independently heteoaryl-Ci-C 4 alkyl or heteroaryl-Ci-C 4 alkyl wherein the heteroaryl moiety is substituted by one to three R 10 , even more preferably each R 9 is independently hydrogen, cyano-Ci- C 8 alkyl, Ci-C 8 alkyl, C 3 -C 8 cycloalkyl, Ci-C 8
- Y 1 , Y 2 , Y 3 , Y 4 , G 1 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 10 are as defined above.
- a preferred embodiment provides compounds of formula (Ia.A) wherein A 1 is C-R 5 , A 2 , A 3 , and A 4 are C-H, R 4 is 3,5-dichloro-phenyl, L is a bond, and G 1 , R 1 , R 2 , R 3 , R 5 , Y 1 , Y 2 , Y 3 and Y 4 are as defined for a compound of formula (I); or a salt or N-oxide thereof.
- a preferred embodiment provides compounds of formula (Ia.B) wherein A 1 is C-Me, A 2 , A 3 , and A 4 are C-H, R 4 is 3,5-dichloro-phenyl, L is a bond, and G 1 , R 1 , R 2 , R 3 , Y 1 , Y 2 , Y 3 and Y 4 are as defined for a compound of formula (I); or a salt or N-oxide thereof.
- a preferred embodiment provides compounds of formula (la.C)
- R 2 is hydrogen or C 1 -C 4 alkyl
- R 3 is C 1 -C 4 haloalkyl
- R 4 is phenyl, or phenyl substituted by one to three R 6 ;
- R 5 is halogen, nitro, Ci-C 4 alkyl, C3-C 4 Cycloalkyl, C 2 -C 4 alkenyl or Ci-C 4 haloalkyl;
- a 3 and A 4 are independently C-H or N;
- L is a bond or methylene
- R 1 , R 6 , Y 1 , Y 2 , Y 3 , and Y 4 are as defined for formula (I);
- Y 1 , Y 2 , Y 3 and Y 4 are heteroatoms; or a salt or N-oxide thereof.
- Preferred values of Y 1 , Y 2 , Y 3 , Y 4 , A 3 , A 4 , R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are as defined for formula I.
- a preferred embodiment provides compounds of formula (Ia.D)
- R 5 , Y 1 , Y 2 , Y 3 , Y 4 and their preferred values are as defined for formula (I);
- a 1 , A 2 , A 3 , A 4 , R 3 , R 4 and R 9 and their preferred values are as defined for a compound of formula (I); or a salt or N-oxide thereof.
- Certain intermediates are novel and as such form a further aspect of the invention.
- a further preferred embodiment provides compounds of formula (Ia.F)
- a 1 , A 2 , A 3 , A 4 , R 3 and R 4 and their preferred values are as defined for a compound of formula (I); or a salt or N-oxide thereof.
- the preferences for A 1 , A 2 , A 3 , A 4 , G 1 , L, R 1 , R 2 , Y 1 , Y 2 , Y 3 and Y 4 are the same as the preferences set out for the corresponding substituents of a compound of formula (I).
- the preferences for AA 11 ,, AA 22 ,, AA 33 ,, AA 44 ,, GG 11 ,, LL,, RR 11 ,, RR 22 ,, YY 11 ,, YY 22 ,, Y 3 and Y 4 may be the same as for formula (Ia.A) (Ia.B), (Ia.C), (Ia.D), (Ia.E) or (Ia.F).
- Another group of novel intermediates are compounds of formula (Int-II)
- a 1 , A 2 , A 3 , A 4 , G 1 , L, R 1 , R 2 , Y 1 , Y 2 , Y 3 and Y 4 are as defined for a compound of formula (I);
- the preferences for A 1 , A 2 , A 3 , A 4 , G 1 , L, R 1 , R 2 , Y 1 , Y 2 , Y 3 and Y 4 are the same as the preferences set out for the corresponding substituents of a compound of formula (I).
- the preferences for A 1 , A 2 , A 3 , A 4 , G 1 , L, R 1 , R 2 , Y 1 , Y 2 , Y 3 and Y 4 may be the same as for formula (Ia.A), (Ia.B), (Ia.C), (Ia.D), (Ia.E) or (Ia.F).
- Table 1 provides compounds of formula (la) wherein R 2 is hydrogen, R 5 is methyl, Y 1 and Y 4 are CH 2 , and R 2 , Y 2 and Y 3 have the values listed in the table below.
- Table 2 provides compounds of formula (lb) wherein G 1 is oxygen, and R 5 and R 9 have the values listed in the table below.
- Compounds of formula I include at least one chiral centre and may exist as compounds of formula I* or compounds of formula I**.
- Compounds I* and I** are enantiomers if there is no other chiral center or epimers otherwise.
- compounds of formula I** are more biologically active than compounds of formula I*.
- the invention includes mixtures of compounds I* and I** in any ratio e.g. in a molar ratio of 1 :99 to 99: 1, e.g. 10:1 to 1 : 10, e.g. a substantially 50:50 molar ratio.
- the molar proportion of compound I** compared to the total amount of both enantiomers is for example greater than 50%, e.g. at least 55, 60, 65, 70, 75, 80, 85, 90, 95, 96, 97, 98, or at least 99%.
- the molar proportion of the compound of formula I* compared to the total amount of both enantiomers (or epimerically) is for example greater than 50%>, e.g. at least 55, 60, 65, 70, 75, 80, 85, 90, 95, 96, 97, 98, or at least 99%.
- Enantiomerically (or epimerically) enriched mixtures of formula I** are preferred.
- the compounds of the invention may be made by a variety of methods as shown in Schemes 1 and 2.
- R is OH
- a coupling reagent such as N,N'-dicyclohexylcarbo- diimide (“DCC”), l-ethyl-3-(3-dimethylamino-propyl)carbodiimide hydrochloride (“EDC”) or bis(2-oxo-3-oxazolidinyl)phosphonic chloride (“BOP-Cl”)
- DCC N,N'-dicyclohexylcarbo- diimide
- EDC l-ethyl-3-(3-dimethylamino-propyl)carbodiimide hydrochloride
- BOP-Cl bis(2-oxo-3-oxazolidinyl)phosphonic chloride
- R When R is CI, such reactions are usually carried out in the presence of a base, and optionally in the presence of a nucleophilic catalyst. Alternatively, it is possible to conduct the reaction in a biphasic system comprising an organic solvent, preferably ethyl acetate, and an aqueous solvent, preferably a solution of sodium hydrogen carbonate.
- a biphasic system comprising an organic solvent, preferably ethyl acetate, and an aqueous solvent, preferably a solution of sodium hydrogen carbonate.
- R Ci-C 6 alkoxy it is sometimes possible to convert the ester directly to the amide by heating the ester and amine together in a thermal process.
- Suitable bases include pyridine, triethylamine, 4-(dimethylamino)-pyridine (“DMAP”) or diisopropylethylamine (Hunig's base).
- Preferred solvents are N,N-dimethylacetamide, tetrahydrofuran, dioxane, 1,2- dimethoxyethane, ethyl acetate and toluene.
- the reaction is carried out at a temperature of from 0°C to 100°C, preferably from 15°C to 30°C, in particular at ambient temperature.
- Amines of formula (III) are either known in the literature or can be prepared using methods known to a person skilled in the art. Some of these methods are described in the preparation Examples.
- Acid halides of formula (II), wherein G 1 is oxygen and R is CI, F or Br may be made from carboxylic acids of formula (II), wherein G 1 is oxygen and R is OH, under standard conditions, as described for example in WO09080250.
- Carboxylic acids of formula (II), wherein G 1 is oxygen and R is OH may be formed from esters of formula (II), wherein G 1 is oxygen and R is Ci-C 6 alkoxy as described for example in WO09080250.
- Compounds of formula (I) wherein G 1 is oxygen can be prepared by reacting a compound of formula (IV) wherein X B is a leaving group, for example a halogen, such as bromo, with carbon monoxide and an amine of formula (III), in the presence of a catalyst, such as palladium(II) acetate or bis(triphenylphosphine)palladium(II) dichloride, optionally in the presence of a ligand, such as triphenylphosphine, and a base, such as sodium carbonate, pyridine, triethylamine, 4-(dimethylamino)-pyridine (“DMAP”) or diisopropylethylamine (Hunig's base), in a solvent, such as water, N,N-dimethylformamide or tetrahydrofuran.
- a catalyst such as palladium(II) acetate or bis(triphenylphosphine)palladium(II) dich
- compounds of formula (I) wherein G is oxygen can be prepared by various methods from an intermediate of formula (V) as shown in Scheme 2 wherein G 1 is oxygen and X B is a leaving group, for example a halogen, such as bromo, or X B is cyano, formyl or acetyl according to similar methods to those described in WO09080250.
- An intermediate of formula (V) can be prepared for example from an intermediate of formula (VI) as described in the same reference.
- the compounds of formula (I) can be used to combat and control infestations of insect pests such as Lepidoptera, Diptera, Hemiptera, Thysanoptera, Orthoptera, Dictyoptera, Coleoptera, Siphonaptera, Hymenoptera and Isoptera and also other invertebrate pests, for example, acarine, nematode and mollusc pests. Insects, acarines, nematodes and molluscs are hereinafter collectively referred to as pests.
- the pests which may be combated and controlled by the use of the invention compounds include those pests associated with agriculture (which term includes the growing of crops for food and fiber products), horticulture and animal husbandry, companion animals, forestry and the storage of products of vegetable origin (such as fruit, grain and timber); those pests associated with the damage of man-made structures and the transmission of diseases of man and animals; and also nuisance pests (such as flies).
- the compounds of the invention may be used for example on turf, ornamentals, such as flowers, shrubs, broad-leaved trees or evergreens, for example conifers, as well as for tree injection, pest management and the like.
- pest species which may be controlled by the compounds of formula (I) include: Myzus persicae (aphid), Aphis gossypii (aphid), Aphis fabae (aphid), Lygus spp.
- Capsids Dysdercus spp. (capsids), Nilaparvata lugens (planthopper), Nephotettixc incticeps (leafhopper), Nezara spp. (stinkbugs), Euschistus spp. (stinkbugs), Leptocorisa spp.
- decemlineata Cold potato beetle
- Anthonomus grandis boll weevil
- Panonychus ulmi European red mite
- Panonychus citri citrus red mite
- Tetranychus urticae two-spotted spider mite
- Tetranychus cinnabarinus carmine spider mite
- Phyllocoptruta oleivora (citrus rust mite), Polyphagotarsonemus latus (broad mite), Brevipalpus spp. (flat mites), Boophilus microplus (cattle tick), Dermacentor variabilis (American dog tick), Ctenocephalides felis (cat flea), Liriomyza spp. (leafminer), Musca domestica (housefly), Aedes aegypti (mosquito), Anopheles spp. (mosquitoes), Culex spp. (mosquitoes), Lucillia spp.
- Rhinotermitidae for example Coptotermes formosanus, Reticulitermes flavipes, R. speratu, R. virginicus, R. hesperus, and R. santonensis
- Termitidae for example Globitermes sulfur eus
- Solenopsis geminata fire ant
- Monomorium pharaonis pharaoh's ant
- Damalinia spp. and Linognathus spp. bits and sucking lice
- Meloidogyne spp. root knot nematodes
- Globodera spp. Globodera spp.
- Heterodera spp. cyst nematodes
- the invention therefore provides a method of combating and/or controlling an animal pest, e.g. an invertebrate animal pest, which comprises applying to the pest, to a locus of the pest, or to a plant susceptible to attack by the pest a pesticidally effective amount of a compound of formula (I).
- an animal pest e.g. an invertebrate animal pest
- applying to the pest to a locus of the pest, or to a plant susceptible to attack by the pest a pesticidally effective amount of a compound of formula (I).
- the invention provides a method of combating and/or controlling insects, acarines, nematodes or molluscs which comprises applying an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I), or a composition containing a compound of formula (I), to a pest, a locus of pest, preferably a plant, or to a plant susceptible to attack by a pest,
- the compounds of formula (I) are preferably used against insects, acarines or nematodes.
- plant as used herein includes seedlings, bushes and trees.
- Crops are to be understood as also including those crops which have been rendered tolerant to herbicides or classes of herbicides (e.g. ALS-, GS-, EPSPS-, PPO- and HPPD- inhibitors) by conventional methods of breeding or by genetic engineering.
- herbicides or classes of herbicides e.g. ALS-, GS-, EPSPS-, PPO- and HPPD- inhibitors
- An example of a crop that has been rendered tolerant to imidazolinones, e.g. imazamox, by conventional methods of breeding is Clearfield® summer rape (canola).
- crops that have been rendered tolerant to herbicides by genetic engineering methods include e.g. glyphosate- and glufosinate -resistant maize varieties commercially available under the trade names
- Crops are also to be understood as being those which have been rendered resistant to harmful insects by genetic engineering methods, for example Bt maize (resistant to European corn borer), Bt cotton (resistant to cotton boll weevil) and also Bt potatoes (resistant to Colorado beetle).
- Bt maize are the Bt 176 maize hybrids of NK® (Syngenta Seeds).
- Examples of transgenic plants comprising one or more genes that code for an insecticidal resistance and express one or more toxins are KnockOut® (maize), Yield Gard® (maize), NuCOTIN33B® (cotton), Bollgard® (cotton), NewLeaf® (potatoes), NatureGard® and Protexcta®.
- Plant crops or seed material thereof can be both resistant to herbicides and, at the same time, resistant to insect feeding ("stacked" transgenic events).
- seed can have the ability to express an insecticidal Cry3 protein while at the same time being tolerant to glyphosate.
- Crops are also to be understood as being those which are obtained by conventional methods of breeding or genetic engineering and contain so-called output traits (e.g. improved storage stability, higher nutritional value and improved flavor).
- output traits e.g. improved storage stability, higher nutritional value and improved flavor.
- a compound of formula (I) is usually formulated into a composition which includes, in addition to the compound of formula (I), a suitable inert diluent or carrier and, optionally, a surface active agent (SFA).
- SFAs are chemicals which are able to modify the properties of an interface (for example, liquid/solid, liquid/air or liquid/liquid interfaces) by lowering the interfacial tension and thereby leading to changes in other properties (for example dispersion, emulsification and wetting).
- compositions both solid and liquid formulations
- the composition is generally used for the control of pests such that a compound of formula (I) is applied at a rate of from O.lg to 10kg per hectare, preferably from lg to 6kg per hectare, more preferably from lg to 1kg per hectare.
- a compound of formula (I) When used in a seed dressing, a compound of formula (I) is used at a rate of 0.000 lg to lOg (for example 0.00 lg or 0.05g), preferably 0.005g to lOg, more preferably 0.005g to 4g, per kilogram of seed.
- the present invention provides a composition comprising a pesticidally effective amount of a compound of formula (I), in particular an insecticidal, acaricidal, nematicidal or molluscicidal composition comprising an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I) and a suitable carrier or diluent therefor.
- the composition is preferably an insecticidal, acaricidal, nematicidal or molluscicidal composition.
- compositions can be chosen from a number of formulation types, including dustable powders (DP), soluble powders (SP), water soluble granules (SG), water dispersible granules (WG), wettable powders (WP), granules (GR) (slow or fast release), soluble concentrates (SL), oil miscible liquids (OL), ultra low volume liquids (UL), emulsifiable concentrates (EC), dispersible concentrates (DC), emulsions (both oil in water (EW) and water in oil (EO)), micro -emulsions (ME), suspension concentrates (SC), aerosols, fogging/smoke formulations, capsule suspensions (CS) and seed treatment formulations.
- the formulation type chosen in any instance will depend upon the particular purpose envisaged and the physical, chemical and biological properties of the compound of formula (I).
- Dustable powders may be prepared by mixing a compound of formula (I) with one or more solid diluents (for example natural clays, kaolin, pyrophyllite, bentonite, alumina, montmorillonite, kieselguhr, chalk, diatomaceous earths, calcium phosphates, calcium and magnesium carbonates, sulfur, lime, flours, talc and other organic and inorganic solid carriers) and mechanically grinding the mixture to a fine powder.
- solid diluents for example natural clays, kaolin, pyrophyllite, bentonite, alumina, montmorillonite, kieselguhr, chalk, diatomaceous earths, calcium phosphates, calcium and magnesium carbonates, sulfur, lime, flours, talc and other organic and inorganic solid carriers
- Soluble powders may be prepared by mixing a compound of formula (I) with one or more water-soluble inorganic salts (such as sodium bicarbonate, sodium carbonate or magnesium sulfate) or one or more water-soluble organic solids (such as a polysaccharide) and, optionally, one or more wetting agents, one or more dispersing agents or a mixture of said agents to improve water dispersibility/solubility. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water soluble granules (SG).
- water-soluble inorganic salts such as sodium bicarbonate, sodium carbonate or magnesium sulfate
- water-soluble organic solids such as a polysaccharide
- WP Wettable powders
- WG Water dispersible granules
- Granules may be formed either by granulating a mixture of a compound of formula (I) and one or more powdered solid diluents or carriers, or from pre-formed blank granules by absorbing a compound of formula (I) (or a solution thereof, in a suitable agent) in a porous granular material (such as pumice, attapulgite clays, fuller's earth, kieselguhr, diatomaceous earths or ground corn cobs) or by adsorbing a compound of formula (I) (or a solution thereof, in a suitable agent) on to a hard core material (such as sands, silicates, mineral carbonates, sulfates or phosphates) and drying if necessary.
- a hard core material such as sands, silicates, mineral carbonates, sulfates or phosphates
- Agents which are commonly used to aid absorption or adsorption include solvents (such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters) and sticking agents (such as polyvinyl acetates, polyvinyl alcohols, dextrins, sugars and vegetable oils).
- solvents such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters
- sticking agents such as polyvinyl acetates, polyvinyl alcohols, dextrins, sugars and vegetable oils.
- One or more other additives may also be included in granules (for example an emulsifying agent, wetting agent or dispersing agent).
- DC Dispersible Concentrates
- a compound of formula (I) may be prepared by dissolving a compound of formula (I) in water or an organic solvent, such as a ketone, alcohol or glycol ether.
- organic solvent such as a ketone, alcohol or glycol ether.
- surface active agent for example to improve water dilution or prevent crystallization in a spray tank.
- Emulsifiable concentrates or oil-in-water emulsions (EW) may be prepared by dissolving a compound of formula (I) in an organic solvent (optionally containing one or more wetting agents, one or more emulsifying agents or a mixture of said agents).
- organic solvents for use in ECs include aromatic hydrocarbons (such as alkylbenzenes or alkylnaphthalenes, exemplified by SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; SOLVESSO is a Registered Trade Mark), ketones (such as cyclohexanone or
- An EC product may spontaneously emulsify on addition to water, to produce an emulsion with sufficient stability to allow spray application through appropriate equipment.
- Preparation of an EW involves obtaining a compound of formula (I) either as a liquid (if it is not a liquid at room temperature, it may be melted at a reasonable temperature, typically below 70°C) or in solution (by dissolving it in an appropriate solvent) and then emulsifiying the resultant liquid or solution into water containing one or more SFAs, under high shear, to produce an emulsion.
- Suitable solvents for use in EWs include vegetable oils, chlorinated hydrocarbons (such as chlorobenzenes), aromatic solvents (such as alkylbenzenes or alkylnaphthalenes) and other appropriate organic solvents which have a low solubility in water.
- Microemulsions may be prepared by mixing water with a blend of one or more solvents with one or more SFAs, to produce spontaneously a thermodynamically stable isotropic liquid formulation.
- a compound of formula (I) is present initially in either the water or the solvent/SFA blend.
- Suitable solvents for use in MEs include those hereinbefore described for use in ECs or in EWs.
- An ME may be either an oil-in-water or a water-in-oil system (which system is present may be determined by conductivity measurements) and may be suitable for mixing water-soluble and oil-soluble pesticides in the same formulation.
- ME is suitable for dilution into water, either remaining as a microemulsion or forming a conventional oil-in-water emulsion.
- SC Suspension concentrates
- SCs may comprise aqueous or non-aqueous suspensions of finely divided insoluble solid particles of a compound of formula (I).
- SCs may be prepared by ball or bead milling the solid compound of formula (I) in a suitable medium, optionally with one or more dispersing agents, to produce a fine particle suspension of the compound.
- One or more wetting agents may be included in the composition and a suspending agent may be included to reduce the rate at which the particles settle.
- a compound of formula (I) may be dry milled and added to water, containing agents hereinbefore described, to produce the desired end product.
- Aerosol formulations comprise a compound of formula (I) and a suitable propellant
- a compound of formula (I) may also be dissolved or dispersed in a suitable medium (for example water or a water miscible liquid, such as n-propanol) to provide compositions for use in non-pressurized, hand-actuated spray pumps.
- a suitable medium for example water or a water miscible liquid, such as n-propanol
- a compound of formula (I) may be mixed in the dry state with a pyrotechnic mixture to form a composition suitable for generating, in an enclosed space, a smoke containing the compound.
- Capsule suspensions may be prepared in a manner similar to the preparation of
- each oil droplet is encapsulated by a polymeric shell and contains a compound of formula (I) and, optionally, a carrier or diluent therefor.
- the polymeric shell may be produced by either an interfacial polycondensation reaction or by a coacervation procedure.
- the compositions may provide for controlled release of the compound of formula (I) and they may be used for seed treatment.
- a compound of formula (I) may also be formulated in a biodegradable polymeric matrix to provide a slow, controlled release of the compound.
- a composition may include one or more additives to improve the biological performance of the composition (for example by improving wetting, retention or distribution on surfaces; resistance to rain on treated surfaces; or uptake or mobility of a compound of formula (I)).
- additives include surface active agents, spray additives based on oils, for example certain mineral oils or natural plant oils (such as soy bean and rape seed oil), and blends of these with other bio-enhancing adjuvants (ingredients which may aid or modify the action of a compound of formula (I)).
- a compound of formula (I) may also be formulated for use as a seed treatment, for example as a powder composition, including a powder for dry seed treatment (DS), a water soluble powder (SS) or a water dispersible powder for slurry treatment (WS), or as a liquid composition, including a flowable concentrate (FS), a solution (LS) or a capsule suspension (CS).
- DS powder for dry seed treatment
- SS water soluble powder
- WS water dispersible powder for slurry treatment
- CS capsule suspension
- the preparations of DS, SS, WS, FS and LS compositions are very similar to those of, respectively, DP, SP, WP, SC and DC compositions described above.
- Compositions for treating seed may include an agent for assisting the adhesion of the composition to the seed (for example a mineral oil or a film-forming barrier).
- Wetting agents, dispersing agents and emulsifying agents may be surface SFAs of the cationic, anionic, amphoteric or non-ionic type.
- Suitable SFAs of the cationic type include quaternary ammonium compounds (for example cetyltrimethyl ammonium bromide), imidazolines and amine salts.
- Suitable anionic SFAs include alkali metals salts of fatty acids, salts of aliphatic monoesters of sulfuric acid (for example sodium lauryl sulfate), salts of sulfonated aromatic compounds (for example sodium dodecylbenzenesulfonate, calcium
- these products may be ethoxylated), sulfosuccinamates, paraffin or olefine sulfonates, taurates and lignosulfonates.
- Suitable SFAs of the amphoteric type include betaines, propionates and glycinates.
- Suitable SFAs of the non-ionic type include condensation products of alkylene oxides, such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof, with fatty alcohols (such as oleyl alcohol or cetyl alcohol) or with alkylphenols (such as octylphenol, nonylphenol or octylcresol); partial esters derived from long chain fatty acids or hexitol anhydrides; condensation products of said partial esters with ethylene oxide; block polymers (comprising ethylene oxide and propylene oxide); alkanolamides; simple esters (for example fatty acid polyethylene glycol esters); amine oxides (for example lauryl dimethyl amine oxide); and lecithins.
- Suitable suspending agents include hydrophilic colloids (such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose) and swelling clays (such as bentonite or attapulgite).
- hydrophilic colloids such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose
- swelling clays such as bentonite or attapulgite.
- a compound of formula (I) may be applied by any of the known means of applying pesticidal compounds.
- the pests or to a locus of the pests such as a habitat of the pests, or a growing plant liable to infestation by the pests
- any part of the plant including the foliage, stems, branches or roots, to the seed before it is planted or to other media in which plants are growing or are to be planted (such as soil surrounding the roots, the soil generally, paddy water or hydroponic culture systems), directly or it may be sprayed on, dusted on, applied by dipping, applied as a cream or paste formulation, applied as a vapor or applied through distribution or
- composition such as a granular composition or a composition packed in a water-soluble bag
- incorporation of a composition in soil or an aqueous environment.
- a compound of formula (I) may also be injected into plants or sprayed onto vegetation using electrodynamic spraying techniques or other low volume methods, or applied by land or aerial irrigation systems.
- compositions for use as aqueous preparations are generally supplied in the form of a concentrate containing a high proportion of the active ingredient, the concentrate being added to water before use.
- These concentrates which may include DCs, SCs, ECs, EWs, MEs, SGs, SPs, WPs, WGs and CSs, are often required to withstand storage for prolonged periods and, after such storage, to be capable of addition to water to form aqueous preparations which remain homogeneous for a sufficient time to enable them to be applied by conventional spray equipment.
- Such aqueous preparations may contain varying amounts of a compound of formula (I) (for example 0.0001 to 10%, by weight) depending upon the purpose for which they are to be used.
- a compound of formula (I) may be used in mixtures with fertilizers (for example nitrogen-, potassium- or phosphorus-containing fertilizers). Suitable formulation types include granules of fertilizer. The mixtures preferably contain up to 25% by weight of the compound of formula (I).
- fertilizers for example nitrogen-, potassium- or phosphorus-containing fertilizers.
- Suitable formulation types include granules of fertilizer.
- the mixtures preferably contain up to 25% by weight of the compound of formula (I).
- the invention therefore also provides a fertilizer composition comprising a fertilizer and a compound of formula (I).
- compositions of this invention may contain other compounds having biological activity, for example micronutrients or compounds having fungicidal activity or which possess plant growth regulating, herbicidal, insecticidal, nematicidal or acaricidal activity.
- the compound of formula (I) may be the sole active ingredient of the composition or it may be admixed with one or more additional active ingredients such as a pesticide, e.g. a insecticide, fungicide or herbicide, or a synergist or plant growth regulator wherein
- An additional active ingredient may provide a composition having a broader spectrum of activity or increased persistence at a locus; synergize the activity or complement the activity (for example by increasing the speed of effect or overcoming repellency) of the compound of formula (I); or help to overcome or prevent the development of resistance to individual components.
- the particular additional active ingredient will depend upon the intended utility of the composition.
- Suitable pesticides include the following: a) Pyrethroids, such as permethrin, cypermethrin, fenvalerate, esfenvalerate, deltamethrin, cyhalothrin (in particular lambda-cyhalothrin and gamma cyhalothrin), bifenthrin, fenpropathrin, cyfluthrin, tefluthrin, fish safe pyrethroids (for example ethofenprox), natural pyrethrin, tetramethrin, S-bioallethrin, fenfluthrin, prallethrin or
- Organophosphates such as profenofos, sulprofos, acephate, methyl parathion, azinphos-methyl, demeton-s-methyl, heptenophos, thiometon, fenamiphos, monocrotophos, profenofos, triazophos, methamidophos, dimethoate, phosphamidon, malathion,
- Carbamates including aryl carbamates
- pirimicarb triazamate
- cloethocarb carbofuran
- furathiocarb furathiocarb
- ethiofencarb aldicarb
- thiofurox carbosulfan
- bendiocarb fenobucarb
- propoxur methomyl or oxamyl
- Benzoyl ureas such as diflubenzuron, triflumuron, hexaflumuron, flufenoxuron, lufeneron or chlorf uazuron;
- Organic tin compounds such as cyhexatin, fenbutatin oxide or azocyclotin;
- Macrolides such as avermectins or milbemycins, for example abamectin, emamectin benzoate, ivermectin, milbemycin, spinosad, azadirachtin or spinetoram;
- Organochlorine compounds such as endosulfan (in particular alpha-endosulfan), benzene hexachloride, DDT, chlordane or dieldrin;
- Amidines such as chlordimeform or amitraz
- Fumigant agents such as chloropicrin, dichloropropane, methyl bromide or metam
- Neonicotinoid compounds such as imidacloprid, thiacloprid, acetamiprid, nitenpyram, dinotefuran, thiamethoxam, clothianidin, nithiazine or f onicamid;
- Diacylhydrazines such as tebufenozide, chromafenozide or methoxyfenozide
- Diphenyl ethers such as diofenolan or pyriproxifen
- Diamides such as flubendiamide, chlorantraniliprole (Rynaxypyr®) or cyantraniliprole; t) Sulfoxaflor; or
- pesticides having particular targets may be employed in the composition, if appropriate for the intended utility of the composition.
- selective insecticides for particular crops for example stemborer specific insecticides (such as cartap) or hopper specific insecticides (such as buprofezin) for use in rice may be employed.
- insecticides or acaricides specific for particular insect species/stages may also be included in the compositions (for example acaricidal ovo-larvicides, such as clofentezine, flubenzimine, hexythiazox or tetradifon; acaricidal motilicides, such as dicofol or propargite; acaricides, such as bromopropylate or chlorobenzilate; or growth regulators, such as hydramethylnon, cyromazine, methoprene, chlorfluazuron or diflubenzuron).
- acaricidal ovo-larvicides such as clofentezine, flubenzimine, hexythiazox or tetradifon
- acaricidal motilicides such as dicofol or propargite
- acaricides such as bromopropylate or chlorobenzilate
- growth regulators such
- fungicidal compounds which may be included in the composition of the invention are (E)-N-methyl-2-[2-(2,5-dimethylphenoxymethyl)phenyl]-2-methoxy- iminoacetamide (SSF-129), 4-bromo-2-cyano-N,N-dimethyl-6-trifluoromethyl- benzimidazole- 1 -sulfonamide, -[N-(3-chloro-2,6-xylyl)-2-methoxyacetamido]-y
- acibenzolar-S-methyl alanycarb, aldimorph, anilazine, azaconazole, azoxystrobin, benalaxyl, benomyl, benthiavalicarb, biloxazol, bitertanol, bixafen, blasticidin S, boscalid, bromuconazole, bupirimate, captafol, captan, carbendazim, carbendazim chlorhydrate, carboxin, carpropamid, carvone, CGA41396, CGA41397, chinomethionate, chlorothalonil, chlorozolinate, clozylacon, copper containing compounds such as copper oxychloride, copper oxyquinolate, copper sulfate, copper tallate and Bordeaux mixture, cyclufenamid, cymoxanil, cyproconazole, cyprodinil, debacarb, di-2-pyridyl disulfide
- the compounds of formula (I) may be mixed with soil, peat or other rooting media for the protection of plants against seed-borne, soil-borne or foliar fungal diseases.
- suitable synergists for use in the compositions include piperonyl butoxide, sesamex, safroxan and dodecyl imidazole.
- Suitable herbicides and plant-growth regulators for inclusion in the compositions will depend upon the intended target and the effect required.
- An example of a rice selective herbicide which may be included is propanil.
- An example of a plant growth regulator for use in cotton is PIXTM.
- Some mixtures may comprise active ingredients which have significantly different physical, chemical or biological properties such that they do not easily lend themselves to the same conventional formulation type.
- other formulation types may be prepared.
- one active ingredient is a water insoluble solid and the other a water insoluble liquid
- the resultant composition is a suspoemulsion (SE) formulation.
- the compounds of the invention are also useful in the field of animal health, e.g. they may be used against parasitic invertebrate pests, more preferably against parasitic
- invertebrate pests in or on an animal.
- pests include nematodes, trematodes, cestodes, flies, mites, tricks, lice, fleas, true bugs and maggots.
- the animal may be a non- human animal, e.g. an animal associated with agriculture, e.g. a cow, a pig, a sheep, a goat, a horse, or a donkey, or a companion animal, e.g. a dog or a cat.
- the invention provides a compound of the invention for use in a method of therapeutic treatment.
- the invention relates to a method of controlling parasitic invertebrate pests in or on an animal comprising administering a pesticidally effective amount of a compound of the invention.
- the administration may be for example oral administration, parenteral administration or external administration, e.g. to the surface of the animal body.
- the invention relates to a compound of the invention for controlling parasitic invertebrate pests in or on an animal.
- the invention relates to use of a compound of the invention in the manufacture of a medicament for controlling parasitic invertebrate pests in or on an animal
- the invention relates to a method of controlling parasitic invertebrate pests comprising administering a pesticidally effective amount of a compound of the invention to the environment in which an animal resides.
- the invention relates to a method of protecting an animal from a parasitic invertebrate pest comprising administering to the animal a pesticidally effective amount of a compound of the invention.
- the invention relates to a compound of the invention for use in protecting an animal from a parasitic invertebrate pest.
- the invention relates to use of a compound of the invention in the manufacture of a medicament for protecting an animal from a parasitic invertebrate pest.
- the invention provides a method of treating an animal suffering from a parasitic invertebrate pest comprising administering to the animal a pesticidally effective amount of a compound of the invention.
- the invention relates to a compound of the invention for use in treating an animal suffering from a parasitic invertebrate pest.
- the invention relates to use of a compound of the invention in the manufacture of a medicament for treating an animal suffering from a parasitic invertebrate pest.
- the invention provides a pharmaceutical composition
- a pharmaceutical composition comprising a compound of the invention and a pharmaceutically suitable excipient.
- the compounds of the invention may be used alone or in combination with one or more other biologically active ingredients.
- the invention provides a combination product comprising a pesticidally effective amount of a component A and a pesticidally effective amount of component B wherein component A is a compound of the invention and component B is a compound as described below.
- the compounds of the invention may be used in combination with anthelmintic agents.
- anthelmintic agents include, compounds selected from the macrocyclic lactone class of compounds such as ivermectin, avermectin, abamectin, emamectin, eprinomectin, doramectin, selamectin, moxidectin, nemadectin and milbemycin derivatives as described in EP- 357460, EP-444964 and EP-594291.
- Additional anthelmintic agents include semisynthetic and biosynthetic avermectin/milbemycin derivatives such as those described in US-5015630, WO-9415944 and WO-9522552. Additional anthelmintic agents include the benzimidazoles such as albendazole, cambendazole, fenbendazole, flubendazole, mebendazole, oxfendazole, oxibendazole, parbendazole, and other members of the class. Additional anthelmintic agents include imidazothiazoles and tetrahydropyrimidmes such as tetramisole, levamisole, pyrantel pamoate, oxantel or morantel.
- Additional anthelmintic agents include flukicides, such as triclabendazole and clorsulon and the cestocides, such as praziquantel and epsiprantel.
- flukicides such as triclabendazole and clorsulon
- cestocides such as praziquantel and epsiprantel.
- the compounds of the invention may be used in combination with derivatives and analogues of the paraherquamide/marcfortine class of anthelmintic agents, as well as the antiparasitic oxazolines such as those disclosed in US-5478855, US- 4639771 and DE- 19520936.
- the compounds of the invention may be used in combination with derivatives and analogues of the general class of dioxomorpholine antiparasitic agents as described in WO- 9615121 and also with anthelmintic active cyclic depsipeptides such as those described in WO-9611945, WO-9319053, WO- 9325543, EP-626375, EP-382173, WO-9419334, EP- 382173, and EP-503538.
- the compounds of the invention may be used in combination with other compounds
- ectoparasiticides for example, fipronil; pyrethroids; organophosphates; insect growth regulators such as lufenuron; ecdysone agonists such as tebufenozide and the like;
- neonicotinoids such as imidacloprid and the like.
- the compounds of the invention may be used in combination with terpene alkaloids, for example those described in International Patent Application Publication Numbers W095/19363 or WO04/72086, particularly the compounds disclosed therein.
- Organophosphates acephate, azamethiphos, azinphos-ethyl, azinphos- methyl, bromophos, bromophos-ethyl, cadusafos, chlorethoxyphos, chlorpyrifos, chlorfenvinphos, chlormephos, demeton, demeton-S-methyl, demeton-S-methyl sulphone, dialifos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, ethoprophos, etrimfos, famphur, fenamiphos, fenitrothion, fensulfothion, fenthion, flupyrazofos, fonofos, formothion, fosthiazate, heptenophos, isazophos, isothioate, isoxathion, malathion, me
- Carbamates alanycarb, aldicarb, 2-sec-butylphenyl methylcarbamate, benfuracarb, carbaryl, carbofuran, carbosulfan, cloethocarb, ethiofencarb, fenoxycarb, fenthiocarb, furathiocarb, HCN-801, isoprocarb, indoxacarb, methiocarb, methomyl, 5-methyl-m- cumenylbutyryl(methyl)carbamate, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, UC-51717.
- Pyrethroids acrinathin, allethrin, alphametrin, 5-benzyl-3-furylmethyl (E) - (1 R)-cis-2,2-dimethyl-3-(2-oxothiolan-3-ylidenemethyl)cyclopropanecarboxylate, bifenthrin, beta -cyfluthrin, cyfluthrin, a-cypermethrin, beta -cypermethrin, bioallethrin, bioallethrin((S)-cyclopentylisomer), bioresmethrin, bifenthrin, NCI-85193, cycloprothrin, 5 cyhalothrin, cythithrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, ethofenprox, fenfluthrin, fenpropathrin, fen
- Arthropod growth regulators a) chitin synthesis inhibitors: benzoylureas:
- antiparasitics acequinocyl, amitraz, AKD-1022, ANS-118, azadirachtin, Bacillus thuringiensis, bensultap, bifenazate, binapacryl, bromopropylate, BTG-504, BTG- 505, camphechlor, cartap, chlorobenzilate, chlordimeform, chlorfenapyr, chromafenozide, clothianidine, cyromazine, diacloden, diafenthiuron, DBI-3204, dinactin,
- ethofenprox fenazaquin, flumite, MTI- 800, fenpyroximate, fluacrypyrim, flubenzimine, flubrocythrinate, flufenzine, flufenprox, fluproxyfen, halofenprox, hydramethylnon, IKI-220, kanemite, NC-196, neem guard, nidinorterfuran, nitenpyram, SD-35651, WL-108477, pirydaryl, propargite, protrifenbute, pymethrozine, pyridaben, pyrimidifen, NC-1111, R-
- spinosad tebufenpyrad, tetradifon, tetranactin, thiacloprid, thiocyclam, thiamethoxam, tolfenpyrad, triazamate, triethoxyspinosyn, trinactin, verbutin, vertalec, YI-5301.
- Fungicides acibenzolar, aldimorph, ampropylfos, andoprim, azaconazole, azoxystrobin, benalaxyl, benomyl, bialaphos, blasticidin-S, Bordeaux mixture,
- bromuconazole bupirimate, carpropamid, captafol, captan, carbendazim, chlorfenazole, chloroneb, chloropicrin, chlorothalonil, chlozolinate, copper oxychloride, copper salts, cyflufenamid, cymoxanil, cyproconazole, cyprodinil, cyprofuram, RH-7281, diclocymet, diclobutrazole, diclomezine, dicloran, difenoconazole, RP-407213, dimethomorph, domoxystrobin, diniconazole, diniconazole-M, dodine, edifenphos, epoxiconazole,
- Biological agents Bacillus thuringiensis ssp aizawai, kurstaki, Bacillus thuringiensis delta endotoxin, baculovirus, entomopathogenic bacteria, virus and fungi.
- Bactericides chlortetracycline, oxytetracycline, streptomycin.
- the compounds of the invention are preferably used in combination with imidacloprid, enrofloxacin, praziquantel, pyrantel embonate, febantel, penethamate, moloxicam, cefalexin, kanamycin, pimobendan, clenbuterol, fipronil, ivermectin, omeprazole, tiamulin, benazepril, milbemycin, cyromazine, thiamethoxam, pyriprole, deltamethrin, cefquinome, florfenicol, buserelin, cefovecin, tulathromycin, ceftiour, selamectin, carprofen, metaflumizone, moxidectin, methoprene (including S -methoprene), clorsulon, pyrantel, amitraz, triclabend
- a combination product of the invention may comprise a pesticidally effective amount of a compound of formula I and pesticidally effective amount of at least one additional parasitic invertebrate pest control active ingredient having a similar spectrum of control but a different site of action.
- salts of chemical compounds are in equilibrium with their corresponding non salt forms, salts share the biological utility of the non salt forms.
- salts of compounds of the invention may be useful for control of invertebrate pests and animal parasites.
- Salts include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids.
- the compounds of the invention also include N-oxides. Accordingly, the invention comprises combinations of compounds of the invention including N-oxides and salts thereof and an additional active ingredient including N-oxides and salts thereof.
- compositions for use in animal health may also contain formulation auxiliaries and additives, known to those skilled in the art as formulation aids (some of which may be considered to also function as solid diluents, liquid diluents or surfactants).
- formulation auxiliaries and additives may control: pH (buffers), foaming during processing (antifoams such polyorganosiloxanes), sedimentation of active ingredients (suspending agents), viscosity (thixotropic thickeners), in-container microbial growth (antimicrobials), product freezing (antifreezes), color (dyes/pigment dispersions), wash-off (film formers or stickers), evaporation (evaporation retardants), and other formulation attributes.
- Film formers include, for example, polyvinyl acetates, polyvinyl acetate copolymers, polyvinylpyrrolidone -vinyl acetate copolymer, polyvinyl alcohols, polyvinyl alcohol copolymers and waxes.
- formulation auxiliaries and additives include those listed in McCutcheon 's Volume 2: Functional Materials, annual International and North American editions published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; and PCT
- the compounds of the invention can be applied without other adjuvants, but most often application will be of a formulation comprising one or more active ingredients with suitable carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use.
- One method of application involves spraying a water dispersion or refined oil solution of the combination products.
- Compositions with spray oils, spray oil concentrations, spreader stickers, adjuvants, other solvents, and synergists such as piperonyl butoxide often enhance compound efficacy.
- Such sprays can be applied from spray containers such as a can, a bottle or other container, either by means of a pump or by releasing it from a pressurized container, e.g., a pressurized aerosol spray can.
- Such spray compositions can take various forms, for example, sprays, mists, foams, fumes or fog. Such spray compositions thus can further comprise propellants, foaming agents, etc. as the case may be.
- a spray composition comprising a pesticidally effective amount of a compound of the invention and a carrier.
- a spray composition comprises a pesticidally effective amount of a compound of the invention and a propellant.
- propellants include, but are not limited to, methane, ethane, propane, butane, isobutane, butene, pentane, isopentane, neopentane, pentene, hydrofluorocarbons, chlorofluorocarbons, dimethyl ether, and mixtures of the foregoing.
- a spray composition (and a method utilizing such a spray composition dispensed from a spray container) used to control at least one parasitic invertebrate pest selected from the group consisting of mosquitoes, black flies, stable flies, deer flies, horse flies, wasps, yellow jackets, hornets, ticks, spiders, ants, gnats, and the like, including individually or in combinations.
- the controlling of animal parasites includes controlling external parasites that are parasitic to the surface of the body of the host animal (e.g., shoulders, armpits, abdomen, inner part of the thighs) and internal parasites that are parasitic to the inside of the body of the host animal (e.g., stomach, intestine, lung, veins, under the skin, lymphatic tissue).
- External parasitic or disease transmitting pests include, for example, chiggers, ticks, lice, mosquitoes, flies, mites and fleas.
- Internal parasites include heartworms, hookworms and helminths.
- the compounds of the invention may be particularly suitable for combating external parasitic pests.
- the compounds of the invention may be suitable for systemic and/or non-systemic control of infestation or infection by parasites on animals.
- the compounds of the invention may be suitable for combating parasitic invertebrate pests that infest animal subjects including those in the wild, livestock and agricultural working animals.
- Livestock is the term used to refer (singularly or plurally) to a
- livestock examples include cattle, sheep, goats, horses, pigs, donkeys, camels, buffalo, rabbits, hens, turkeys, ducks and geese (e.g., raised for meat, milk, butter, eggs, fur, leather, feathers and/or wool).
- fatalities and performance reduction in terms of meat, milk, wool, skins, eggs, etc. are reduced, so that applying the compounds of the invention allows more economic and simple husbandry of animals.
- the compounds of the invention may be suitable for combating parasitic invertebrate pests that infest companion animals and pets (e.g., dogs, cats, pet birds and aquarium fish), research and experimental animals (e.g., hamsters, guinea pigs, rats and mice), as well as animals raised for/in zoos, wild habitats and/or circuses.
- companion animals and pets e.g., dogs, cats, pet birds and aquarium fish
- research and experimental animals e.g., hamsters, guinea pigs, rats and mice
- the animal is preferably a vertebrate, and more preferably a mammal, avian or fish.
- the animal subject is a mammal (including great apes, such as humans).
- Other mammalian subjects include primates (e.g., monkeys), bovine (e.g., cattle or dairy cows), porcine (e.g., hogs or pigs), ovine (e.g., goats or sheep), equine (e.g., horses), canine (e.g., dogs), feline (e.g., house cats), camels, deer, donkeys, buffalos, antelopes, rabbits, and rodents (e.g., guinea pigs, squirrels, rats, mice, gerbils, and hamsters).
- primates e.g., monkeys
- bovine e.g., cattle or dairy cows
- porcine e.g., hogs or pigs
- ovine
- Avians include Anatidae (swans, ducks and geese), Columbidae (e.g., doves and pigeons), Phasianidae (e.g., partridges, grouse and turkeys),
- Thesienidae e.g., domestic chickens
- Psittacines e.g., parakeets, macaws, and parrots
- game birds e.g., game birds, and ratites (e.g., ostriches).
- ratites e.g., ostriches
- Birds treated or protected by the compounds of the invention can be associated with either commercial or noncommercial aviculture. These include Anatidae, such as swans, geese, and ducks, Columbidae, such as doves and domestic pigeons, Phasianidae, such as partridge, grouse and turkeys, Thesienidae, such as domestic chickens, and Psittacines, such as parakeets, macaws and parrots raised for the pet or collector market, among others.
- Anatidae such as swans, geese, and ducks
- Columbidae such as doves and domestic pigeons
- Phasianidae such as partridge, grouse and turkeys
- Thesienidae such as domestic chickens
- Psittacines such as parakeets, macaws and parrots raised for the pet or collector market, among others.
- fish is understood to include without limitation, the Teleosti grouping of fish, i.e., teleosts. Both the Salmoniformes order (which includes the Salmonidae family) and the Perciformes order (which includes the
- Centrarchidae family are contained within the Teleosti grouping.
- Examples of potential fish recipients include the Salmonidae, Serranidae, Sparidae, Cichlidae, and Centrarchidae, among others.
- inventions are also contemplated to benefit from the inventive methods, including marsupials (such as kangaroos), reptiles (such as farmed turtles), and other economically important domestic animals for which the inventive methods are safe and effective in treating or preventing parasite infection or infestation.
- marsupials such as kangaroos
- reptiles such as farmed turtles
- other economically important domestic animals for which the inventive methods are safe and effective in treating or preventing parasite infection or infestation.
- Examples of parasitic invertebrate pests controlled by administering a pesticidally effective amount of the compounds of the invention to an animal to be protected include ectoparasites (arthropods, acarines, etc.) and endoparasites (helminths, e.g., nematodes, trematodes, cestodes, acanthocephalans, etc.).
- ectoparasites arthropods, acarines, etc.
- endoparasites e.g., nematodes, trematodes, cestodes, acanthocephalans, etc.
- helminthiasis The disease or group of diseases described generally as helminthiasis is due to infection of an animal host with parasitic worms known as helminths.
- helminths The term 'helminths' is meant to include nematodes, trematodes, cestodes and acanthocephalans.
- Helminthiasis is a prevalent and serious economic problem with domesticated animals such as swine, sheep, horses, cattle, goats, dogs, cats and poultry.
- the group of worms described as nematodes causes
- Nematodes that are contemplated to be treated by the compounds of the invention include, without limitation, the following genera: Acanthocheilonema, Aelurostrongylus,
- Dictyocaulus Dictyocaulus, Capillaria, Heterakis, Toxocara, Ascaridia, Oxyuris, Ancylostoma, Uncinaria, Toxascaris and Parascaris. Certain of these, such as Nematodirus, Cooperia and
- Trematodes that are contemplated to be treated by the invention and by the inventive methods include, without limitation, the following genera: Alaria, Fasciola, Nanophyetus, Opisthorchis, Paragonimus and Schistosoma.
- Cestodes that are contemplated to be treated by the invention and by the inventive methods include, without limitation, the following genera: Diphyllobothrium, Diplydium, Spirometra and Taenia.
- the most common genera of parasites of the gastrointestinal tract of humans are Ancylostoma, Necator, Ascaris, Strongy hides, Trichinella, Capillaria, Trichuris and Enterobius.
- Other medically important genera of parasites which are found in the blood or other tissues and organs outside the gastrointestinal tract are the filarial worms such as Wuchereria, Brugia, Onchocerca and Loa, as well as Dracunculus and extra intestinal stages of the intestinal worms Strongyloides and Trichinella.
- the compounds of the invention may be effective against a number of animal ectoparasites (e.g., arthropod ectoparasites of mammals and birds).
- animal ectoparasites e.g., arthropod ectoparasites of mammals and birds.
- Insect and acarine pests include, e.g., biting insects such as flies and mosquitoes, mites, ticks, lice, fleas, true bugs, parasitic maggots, and the like.
- Adult flies include, e.g., the horn fly or Haematobia irritans, the horse fly or
- Tabanus spp. the stable fly or Stomoxys calcitrans, the black fly or Simulium spp., the deer fly or Chrysops spp., the louse fly or Melophagus ovinus, and the tsetse fly or Glossina spp.
- Parasitic fly maggots include, e.g., the bot fly ⁇ Oestrus ovis and Cuterebra spp.), the blow fly or Phaenicia spp., the screwworm or Cochliomyia hominivorax, the cattle grub or Hypoderma spp., the fleeceworm and the Gastrophilus of horses.
- Mosquitoes include, for example, Culex spp., Anopheles spp. and Aedes spp.
- Mites include Mesostigmalphatalpha spp. e.g., mesostigmatids such as the chicken mite, Dermalphanyssus galphallinalphae; itch or scab mites such as Sarcoptidae spp. for example, Salpharcoptes scalphabiei; mange mites such as Psoroptidae spp. including Chorioptes bovis and Psoroptes ovis; chiggers e.g., Trombiculidae spp. for example the North American chigger, Trombiculalpha alphalfreddugesi.
- mesostigmatids such as the chicken mite, Dermalphanyssus galphallinalphae
- itch or scab mites such as Sarcoptidae spp. for example, Salpharcoptes scalphabiei
- mange mites such as Psoroptidae spp. including Chorioptes
- Ticks include, e.g., soft-bodied ticks including Argasidae spp. for example Argalphas spp. and Ornithodoros spp.; hard-bodied ticks including Ixodidae spp., for example
- Rhipicephalphalus sanguineus Dermacentor variabilis, Dermacentor andersoni, Amblyomma americanum, Ixodes scapularis and other Rhipicephalus spp. (including the former Boophilus genera).
- Lice include, e.g., sucking lice, e.g., Menopon spp.
- biting lice e.g., Haematopinus spp., Linognathus spp. and Solenopotes spp.
- Fleas include, e.g., Ctenocephalides spp., such as dog flea (Ctenocephalides canis) and cat flea ⁇ Ctenocephalides felis); Xenopsylla spp. such as oriental rat flea (Xenopsylla cheopis); and Pulex spp. such as human flea (Pulex irritans).
- Ctenocephalides spp. such as dog flea (Ctenocephalides canis) and cat flea ⁇ Ctenocephalides felis
- Xenopsylla spp. such as oriental rat flea (Xenopsylla cheopis)
- Pulex spp. such as human flea (Pulex irritans).
- True bugs include, e.g., Cimicidae or e.g., the common bed bug (Cimex lectularius); Triatominae spp. including triatomid bugs also known as kissing bugs; for example
- flies, fleas, lice, mosquitoes, gnats, mites, ticks and helminths cause tremendous losses to the livestock and companion animal sectors.
- Arthropod parasites also are a nuisance to humans and can vector disease-causing organisms in humans and animals.
- the compounds of the invention may also be effective against ectoparasites including: flies such as Haematobia (Lyperosia) irritans (horn fly), Simulium spp. (blackfly), Glossina spp. (tsetse flies), Hydrotaea irritans (head fly), Musca autumnalis (face fly), Musca domestica (house fly), Morellia simplex (sweat fly), Tabanus spp. (horse fly), Hypoderma bovis, Hypoderma lineatum, Lucilia sericata, Lucilia cuprina (green blowfly), Calliphora spp.
- flies such as Haematobia (Lyperosia) irritans (horn fly), Simulium spp. (blackfly), Glossina spp. (tsetse flies), Hydrotaea irritans (head fly), Musca autumnalis (face fly), Musca domestic
- Treatments of the invention are by conventional means such as by enteral
- administration in the form of, for example, tablets, capsules, drinks, drenching preparations, granulates, pastes, boli, feed-through procedures, or suppositories; or by parenteral administration, such as, for example, by injection (including intramuscular, subcutaneous, intravenous, intraperitoneal) or implants; or by nasal administration.
- parenteral administration such as, for example, by injection (including intramuscular, subcutaneous, intravenous, intraperitoneal) or implants; or by nasal administration.
- compounds of the invention When compounds of the invention are applied in combination with an additional biologically active ingredient, they may be administered separately e.g. as separate compositions.
- the biologically active ingredients may be administered simultaneously or sequentially.
- the biologically active ingredients may be components of one composition.
- the compounds of the invention may be administered in a controlled release form, for example in subcutaneous or orally adminstered slow release formulations.
- a parasiticidal composition according to the present invention comprises a compound of the invention, optionally in combination with an additional biologically active ingredient, or N-oxides or salts thereof, with one or more pharmaceutically or veterinarily acceptable carriers comprising excipients and auxiliaries selected with regard to the intended route of administration (e.g., oral or parenteral administration such as injection) and in accordance with standard practice.
- a suitable carrier is selected on the basis of compatibility with the one or more active ingredients in the composition, including such considerations as stability relative to pH and moisture content. Therefore of note are compounds of the invention for protecting an animal from an invertebrate parasitic pest comprising a parasitically effective amount of a compound of the invention, optionally in combination with an additional biologically active ingredient and at least one carrier.
- the compounds of the invention can be formulated in suspension, solution or emulsion in oily or aqueous vehicles, and may contain adjuncts such as suspending, stabilizing and/or dispersing agents.
- compositions for injection include aqueous solutions of water-soluble forms of active ingredients (e.g., a salt of an active compound), preferably in physiologically compatible buffers containing other excipients or auxiliaries as are known in the art of pharmaceutical formulation. Additionally, suspensions of the active compounds may be prepared in a lipophilic vehicle. Suitable lipophilic vehicles include fatty oils such as sesame oil, synthetic fatty acid esters such as ethyl oleate and triglycerides, or materials such as liposomes.
- Aqueous injection suspensions may contain substances that increase the viscosity of the suspension, such as sodium carboxymethyl cellulose, sorbitol, or dextran.
- Formulations for injection may be presented in unit dosage form, e.g., in ampoules or in multi-dose containers.
- the active ingredient may be in powder form for constitution with a suitable vehicle, e.g., sterile, pyrogen-free water, before use.
- the compounds of the invention may also be formulated as a depot preparation. Such long acting formulations may be
- the compounds of the invention may be formulated for this route of administration with suitable polymeric or hydrophobic materials (for instance, in an emulsion with a pharmacologically acceptable oil), with ion exchange resins, or as a sparingly soluble derivative such as, without limitation, a sparingly soluble salt.
- the compounds of the invention can be delivered in the form of an aerosol spray using a pressurized pack or a nebulizer and a suitable propellant, e.g., without limitation, dichlorodifluoromethane, trichlorofluoromethane, dichlorotetrafluoroethane or carbon dioxide.
- a suitable propellant e.g., without limitation, dichlorodifluoromethane, trichlorofluoromethane, dichlorotetrafluoroethane or carbon dioxide.
- the dosage unit may be controlled by providing a valve to deliver a metered amount.
- Capsules and cartridges of, for example, gelatin for use in an inhaler or insufflator may be formulated containing a powder mix of the compound and a suitable powder base such as lactose or starch.
- the compounds of the invention may have favourable pharmacokinetic and pharmacodynamic properties providing systemic availability from oral administration and ingestion. Therefore after ingestion by the animal to be protected, parasiticidally effective concentrations of a compound of the invention in the bloodstream may protect the treated animal from blood-sucking pests such as fleas, ticks and lice. Therefore of note is a composition for protecting an animal from an invertebrate parasite pest in a form for oral administration (i.e. comprising, in addition to a parasiticidally effective amount of a compound of the invention, one or more carriers selected from binders and fillers suitable for oral administration and feed concentrate carriers).
- the compounds of the invention can be formulated with binders/fillers known in the art to be suitable for oral administration compositions, such as sugars and sugar derivatives (e.g., lactose, sucrose, mannitol, sorbitol), starch (e.g., maize starch, wheat starch, rice starch, potato starch), cellulose and derivatives (e.g., methylcellulose, carboxymethylcellulose, ethylhydroxycellulose), protein derivatives (e.g., zein, gelatin), and synthetic polymers (e.g., polyvinyl alcohol, polyvinylpyrrolidone).
- sugars and sugar derivatives e.g., lactose, sucrose, mannitol, sorbitol
- starch e.g., maize starch, wheat starch, rice starch, potato starch
- cellulose and derivatives e.g., methylcellulose, carboxymethylcellulose, ethylhydroxycellulose
- protein derivatives e.
- lubricants e.g., magnesium stearate
- disintegrating agents e.g., cross-linked polyvinylpyrrolidinone, agar, alginic acid
- dyes or pigments can be added.
- Pastes and gels often also contain adhesives (e.g., acacia, alginic acid, bentonite, cellulose, xanthan gum, colloidal magnesium aluminum silicate) to aid in keeping the composition in contact with the oral cavity and not being easily ejected.
- a composition of the present invention is formulated into a chewable and/or edible product (e.g., a chewable treat or edible tablet).
- a chewable and/or edible product e.g., a chewable treat or edible tablet.
- Such a product would ideally have a taste, texture and/or aroma favored by the animal to be protected so as to facilitate oral administration of the compounds of the invention.
- the carrier is typically selected from high-performance feed, feed cereals or protein concentrates.
- Such feed concentrate-containing compositions can, in addition to the parasiticidal active ingredients, comprise additives promoting animal health or growth, improving quality of meat from animals for slaughter or otherwise useful to animal husbandry.
- additives can include, for example, vitamins, antibiotics, chemotherapeutics, bacteriostats, fungistats, coccidiostats and hormones.
- the compound of the invention may also be formulated in rectal compositions such as suppositories or retention enemas, using, e.g., conventional suppository bases such as cocoa butter or other glycerides.
- the formulations for the method of this invention may include an antioxidant, such asBHT (butylated hydroxytoluene).
- the antioxidant is generally present in amounts of at 0.1- 5 percent (wt/vol).
- Some of the formulations require a solubilizer, such as oleic acid, to dissolve the active agent, particularly if spinosad is included.
- Common spreading agents used in these pour-on formulations include isopropyl myristate, isopropyl palmitate, caprylic/capric acid esters of saturated C 12 -C 18 fatty alcohols, oleic acid, oleyl ester, ethyl oleate, triglycerides, silicone oils and dipropylene glycol methyl ether.
- the pour-on formulations for the method of this invention are prepared according to known techniques. Where the pour-on is a solution, the parasiticide/insecticide is mixed with the carrier or vehicle, using heat and stirring if required. Auxiliary or additional ingredients can be added to the mixture of active agent and carrier, or they can be mixed with the active agent prior to the addition of the carrier. Pour-on formulations in the form of emulsions or suspensions are similarly prepared using known techniques.
- Liposomes and emulsions are well-known examples of delivery vehicles or carriers for hydrophobic drugs.
- organic solvents such as dimethylsulfoxide may be used, if needed.
- the rate of application required for effective parasitic invertebrate pest control (e.g. "pesticidally effective amount”) will depend on such factors as the species of parasitic invertebrate pest to be controlled, the pest's life cycle, life stage, its size, location, time of year, host crop or animal, feeding behavior, mating behavior, ambient moisture, temperature, and the like.
- One skilled in the art can easily determine the pesticidally effective amount necessary for the desired level of parasitic invertebrate pest control.
- the compounds of the invention are administered in a pesticidally effective amount to an animal, particularly a homeothermic animal, to be protected from parasitic invertebrate pests.
- a pesticidally effective amount is the amount of active ingredient needed to achieve an observable effect diminishing the occurrence or activity of the target parasitic invertebrate pest.
- the pesticidally effective dose can vary for the various compounds and compositions useful for the method of the present invention, the desired pesticidal effect and duration, the target parasitic invertebrate pest species, the animal to be protected, the mode of application and the like, and the amount needed to achieve a particular result can be determined through simple experimentation.
- a dose of the compositions of the present invention administered at suitable intervals typically ranges from about 0.01 mg/kg to aboutlOO mg/kg, and preferably from about 0.01 mg/kg to about 30 mg/kg of animal body weight.
- Suitable intervals for the administration of the compositions of the present invention to animals range from about daily to about yearly. Of note are administration intervals ranging from about weekly to about once every 6 months. Of particular note are monthly adminstration intervals (i.e. administering the compounds to the animal once every month).
- MS ZQ Mass Spectrometer from Waters single quadrupole mass spectrometer
- ionization method electrospray, polarity: positive ionization, capillary (kV) 3.00, cone (V) 30.00, source temperature (°C) 100, desolvation temperature (°C) 250, cone gas flow (L/Hr) 50, desolvation gas flow (L/Hr) 400, mass range: 150 to 1000 Da.
- MS ZMD Mass Spectrometer from Waters single quadrupole mass spectrometer
- ionization method electrospray, polarity: positive ionization, capillary (kV) 3.00, cone (V) 30.00, extractor (V) 3.00, source temperature (°C) 150, desolvation temperature (°C) 320, cone gas flow (L/Hr) 50, desolvation gas flow (L/Hr) 400, mass range: 150 to 800 Da.
- MS ZQ Mass Spectrometer from Waters single quadrupole mass spectrometer
- ionization method electrospray, polarity: positive ionization, capillary (kV) 3.00, cone (V) 30.00, extractor (V) 3.00, source temperature (°C) 100, desolvation temperature (°C) 200, cone gas flow (L/Hr) 200, desolvation gas flow (L/Hr) 250, mass range: 150 to 800 Da.
- MS ZQ Mass Spectrometer from Waters single quadrupole mass spectrometer
- ionization method electrospray, polarity: positive ionization, capillary (kV) 3.00, cone (V) 30.00, extractor (V) 3.00, source temperature (°C) 100, desolvation temperature (°C) 200, cone gas flow (L/Hr) 200, desolvation gas flow (L/Hr) 250, mass range: 150 to 800 Da.
- MS Thermo Finnigan Surveyor MSQ PLUS single quadrupole mass spectrometer
- ionization method Chemical Ionization, polarity: positive and negative simultaneous ionization, capillary (kV) 4.00, cone (V) 50.00, source
- Step A Thioacetic acid S-(3-acetylsulfanyl-2-tert-butoxycarbonylamino-propyl) ester
- Step B r i,21Dithiolan-4-yl-carbamic acid tert-butyl ester
- Step D 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl1-N-
- Oxalyl chloride (0.122 ml) was added to a solution of 4-[5-(3,5-dichloro-phenyl)-5- trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-benzoic acid (0.5 g) (prepared according to WO 2009/080250) in dichloromethane (3 ml). After addition of two drops of N,N-dimethylformamide (“DMF”) the reaction mixture was stirred at ambient temperature for 18 hours. The reaction mixture was concentrated to give the acid chloride as a yellow solid, which was used in the next step without further purification.
- DMF N,N-dimethylformamide
- D-cycloserine (21 mg) was added to a solution of the acid chloride (45mg) and triethylamine (0.1 ml) in toluene (2 ml). The reaction mixture was stirred at 50 °C for 16 hours. The reaction mixture was diluted with water and ethyl acetate and the phases were separated. The organic phase was washed twice with water, dried over sodium sulfate and concentrated. The residue was purified by chromatography on silica gel (eluent: dichloromethane / methanol 5%) to give the title compound (28 mg) as a colorless solid.
- Step A ((R)-2-Methyl-3-oxo-isoxazolidin-4-yl)-carbamic acid tert-butyl ester
- Step B (R)-4-Amino-2-ethyl-isoxazolidin-3-one
- Step B The BOC protecting group was removed as described in Example 3, Step B to afford (R)-4- amino-2-ethyl-isoxazolidin-3-one (trifluoroacetic acid salt), which was used directly in the next step.
- Step C 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro-isoxazol-3-yll-2-methyl-
- Step A ((R)-2-(hvdroxy-ethyl)-3-oxo-isoxazolidin-4-yl)-carbamic acid tert-butyl ester
- Example 6 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl1-2- methyl-N-((R)-2-(thietan-3-yl)-3-oxo-isoxazolidin-4-yl)-benzamide (compound BIO) Step A: ((R)-2-(thietan-3yl)-3-oxo-isoxazolidin-4-yl)-carbamic acid tert-butyl ester
- Step B (R)-4-Amino-2-(thietan-3-yl)-isoxazolidin-3-one
- Step A Using the product obtained in Step A (43 mg), the BOC protecting group was removed as described in Example 3, Step B to afford the title product, which was used diretly in the next step.
- LCMS Method Hod A 0.17 min, M-H 175.
- Step C 4-r5-(3,5-Dichloro-phenyl)-5-trifluoro
- Example 7 General method for preparing the compounds of the invention in parallel
- Step A (R)-2-Oxo-21ambda l,21oxathiolan-4-ylamine trifluoroacetic acid salt
- Step B 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro-isoxazol-3-yl1-2-methyl- N-(2-oxo-21ambda*4*-ri,21oxathiolan-4-yl)-benzamide
- Oxalyl chloride (0.027 ml) was added to a solution of 4-[5-(3,5-dichloro-phenyl)-5- trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-benzoic acid (100 mg) (prepared according to WO 2009/080250) in dichloromethane (1.2 ml). After addition of two drops of A ,N-dimethylformamide (“DMF”) the reaction mixture was stirred at ambient temperature for 18 hours. The reaction mixture was concentrated to give the acid chloride as a yellow solid, which was used in the next step without further purification.
- DMF ,N-dimethylformamide
- Step A N-(3 -Benzyloxy-2-hvdroxy-prop vD-N-ethyl-methanesulfonamide
- Triethylamine (0.043 ml, 0.1 equiv) was added to a mixture of N-ethylmethanesulfonamide (413 mg, 1.1 equiv) and 2-benzyloxymethyloxirane (500 mg, 3.04 mmol) prepared according to (J. Am. Chem. Soc, 1996, 118, 7094-7100) in anhydrous dioxane (1 ml). The reaction mixture was then heated to 50°C overnight. As the reaction was not complete, it was heated to 100°C for another 5 hours (reaction complete according to TLQ.The volatiles were then removed in vacuo.
- Step B 4-Benzyloxymethyl-2-ethyl-isothiazolidine 1,1 -dioxide
- Step C (2-Ethyl-lJ-dioxo-llambda'
- Step D 2-(2-Ethyl- 1 , 1 -dioxo-1 lambda* 6* -isothiazolidin-4-ylmethyl)-isoindole- 1 ,3-dione
- Step E C-(2-Ethyl-l , 1 -dioxo- 1 lambda*6*-isothiazolidin-4-yl)-methylamine
- Step F 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro-isoxazol-3-yl1-N-(2-ethyl-
- Oxalyl chloride (0.027 ml) was added to a solution of 4-[5-(3,5-dichloro-phenyl)-5- trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-benzoic acid (100 mg) (prepared according to WO 2009/080250) in dichloromethane (1.2 ml). After addition of two drops of N,N-dimethylformamide (“DMF”) the reaction mixture was stirred at ambient temperature for 18 hours. The reaction mixture was concentrated to give the acid chloride as a yellow solid, which was used in the next step without further purification.
- DMF N,N-dimethylformamide
- Step A 2-r4-(2-Nitro-benzenesulfonylamino)-isoxazolidine-2-carbonyl1-benzoic acid methyl ester
- Triethyl amine (0.11 ml, 0.1 equiv) was added to a mixture of N-hydroxyphthalimide (1.13 g, 6.9 mmol) and 2-Bromomethyl-l-(2-nitro-benzenesulfonyl)-aziridine (7.6 mmol, 1.1 equiv) (prepared according to Org. Biomol. Chem. 2008, 6, 1902-1904) in anhydrous dioxane (4.5 ml). The reaction mixture was then heated to 50°C over the weekend. Then methanol (2.5 ml) and triethyl amine (1.1 ml, 1 equiv) were added and the reaction mixture was heated at
- Step C 2-(4- ⁇ 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl1-2- methyl-benzoylamino
- Oxalyl chloride (0.037 ml) was added to a solution of 4-[5-(3,5-dichloro-phenyl)-5- trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-benzoic acid (135 mg) (prepared according to WO 2009/080250) in dichloromethane (1.6 ml). After addition of two drops of A ,N-dimethylformamide (“DMF”) the reaction mixture was stirred at ambient temperature for 18 hours. The reaction mixture was concentrated to give the acid chloride as a yellow solid, which was used in the next step without further purification.
- DMF ,N-dimethylformamide
- Step F 4- ⁇ 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl1-2- methyl-benzoylamino
- Oxalyl chloride (0.20 ml) was added to a solution of 4-[5-(3,5-dichloro-phenyl)-5- trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-benzoic acid (749 mg) (prepared according to WO 2009/080250) in dichloromethane (9 ml). After addition of two drops of A ,N-dimethylformamide (“DMF”) the reaction mixture was stirred at ambient temperature for 18 hours. The reaction mixture was concentrated to give the acid chloride as a yellow solid, which was used in the next step without further purification.
- DMF ,N-dimethylformamide
- Step H 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro-isoxazol-3-yl1-N-(2-ethyl- isoxazolidin-4-yl)-2-methyl-benzamide
- Example 11 4-r5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl1-2-methyl-N- IY2-oxido-l ,3,2-dioxathiolan-2-ium-4-yl)methyl1benzamide (Compound F5) Step A: Preparation of 4-r5-(3,5-dichloro-phenyl)-5-methyl-4,5-dihvdro-isoxazol-3-yl1-N- (2,3-dihvdroxy-propyl)-2-methylbenzamide
- Step B Preparation of 4-r5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl1-2- methyl-N-r(2-oxido- 1 ,3 ,2-dioxathiolan-2-ium-4-yl)methyl1benzamide
- Diastereoisomer 1 LCMS (Method G) 4.07 min, MH + 536. 'HNMR (CDC1 3 , 400 MHz): 7.37-7.50 (m, 6H), 6.26 (m, 1H), 5.16 (m, 1H), 4.79 (m, 1H), 4.32 (m, 1H), 4.10 (m, 2H), 3.71 (m, 2H), 2.45 (s, 3H).
- Diastereoisomer 2 LCMS (Method G) 4.17 min, MH + 536. ! HNMR (CDC1 3 , 400 MHz): 7.47-7.52 (m, 5H), 7.42 (s, 1H), 6.58 (m, 1H), 4.88 (m, 1H), 4.59 (m, 1H), 4.47 (m, 1H), 4.10 (m, 2H), 3.75 (m, 2H), 2.45 (s, 3H).
- Step A (2-Benzyl-isoxazolidin-5-ylmethyl)-carbamic acid tert-butyl ester
- N-BOC-allylamine (2 g) was dissolved in toluene (130 ml) and ethanol (45 ml) then benzylhydroxylamine hydrochloride (3.05 g), paraformaldehyde (3.16 g) and triethylamine (1.93 g) were added.
- the reaction mixture was allowed to stir at room temperature for 24 hours, then the solvent was evaporated in vacuo.
- the resulting residue was diluted in ethyl acetate and the hydrochloride salt of triethylamine was filtered off.
- Step C N-(2 -Benzyl -isoxazolidin-5-ylmethyl)-4-r5-(3,5-dichloro-phenyl)-5-trifluoromethyl- 4,5-dihydro-isoxazol-3-yl1-2-meth l-benzamide
- Example 12 N-(2-methyl-isoxazolidin-5-ylmethyl)-4-[5-(3,5-dichloro-phenyl)-5- trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-benzamide (compound F2).
- Example 13 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl1-2- methyl-N-r3-oxo-2-ethyl-isoxazolidin-5-ylmethyl1-benzamide (compound F3)
- Step A (3-Bromo-4,5-dihvdro-isoxazol-5-ylmethyl)-carbamic acid tert-butyl ester
- N-BOC-allylamine (1.8 g) was dissolved in ethyl acetate and treated with sodium hydrogenocarbonate (4.38 g) and dibromoformaldoxime (2.55 g). The reaction mixture was stirred at room temperature for 4 hours, then poured into water, extracted with ethyl acetate, the organic layer was dried over sodium sulfate and the solvent removed in vacuo. The title crude product was thus obtained as a colorless oil (3.16 g). LCMS (Method F) 1.48 min, M+H 179/181 (M-BOC).
- Step B (3-Oxo-isoxazolidin-5-ylmethyl)-carbamic acid tert-butyl ester
- Step A the crude product obtained in Step A (1.5 g) was dissolved in THF and treated with IN aqueous sodium hydroxide (150 ml) in the presence of tetrabutyl ammonium sulfate (0.54 g). After 24 hours stirring at room temperature, aqueous sodium hydroxide (IN, 50 ml) was added again and the reaction mixture stirred for another 48 hours at 60°C. The reaction mixture was then cooled to room temperature, extracted with diethyl ether and the pH of the aqueous layer adjusted to 1 by addition of 2N HCL.
- IN aqueous sodium hydroxide
- Step B The product obtained in Step B (0.1 g) was alkylated with bromoethane as described in
- Example 4 step A to afford the O-alkylated product (18 mg), ! HNMR (CDCI 3 , 400 MHz): 4.90 (m, 1H), 4.70 (m, 1H), 4.2 (q, 2H), 3.35 (m, 2H), 3.00 (dd, 1H), 2.75 (dd, 1H), 1.50 (s, 9H), 1.35 (t, 3H); and the title N-alkylated product (63 mg). !
- Step E 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro-isoxazol-3-yl1-2-methyl- N-r3-oxo-2-ethyl-isoxazolidin-5-ylmethyl1-benzamide
- Example 14 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl1-N-r2- (4-methoxy-phenvD-l , 1 -dioxo- 1 lambda*6'
- Step C r2-(4-Methoxy-phenyl)- 1 , 1 -dioxo- 1 lambda* 6 * -isothiazolidin-5 -ylmethyll -carbamic acid tert-butyl ester
- Step B To a solution at 0°C of the product obtained in Step B (500 mg) in methanol (15 ml) were added di-tert-butyldicarbonate (807 mg) and nickel(II) chloride hexahydrate (90 mg).
- Step D 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl1-N-r2-(4- methoxy-phenvD- 1 , 1 -dioxo- 1 lambda* 6 * -isothiazolidin-5 -ylmethyll -2-metfiyl-benzamide
- Step C The compound obtained in Step C (94 mg) was deprotected and coupled with 4- [5 -(3,5- dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-benzoic acid (0.125 g) (prepared according to WO 2009/080250) as described in Example 4, Steps B and C to afford the title compound as a brown solid (65 mg).
- Example 15 Preparation of enantiomerically pure isomers of 4-r5-(3,5-dichloro-phenyl)-5- trifluoromethyl-4,5-dihvdro-isoxazol-3-yl1-2-methyl-N-(2-ethyl-3-oxo-isoxazolidin-4-yl)- benzamide
- Step A r(R)-2-(2,2-Difluoro-ethyl)-3-oxo-isoxazolidin-4-yl1-carbamic acid tert-butyl ester
- Step A (3-oxo-isoxazolidin-4-yl)-carbamic acid tert-butyl ester (0.30 g) was alkylated with 2,2-difluoroethyl trifluoromethanesulfonate (0.35g).
- Step B (R)-4-Amino-2-(2,2-difluoroethyl)-isoxazolidin-3-one
- Step C 4-r5-(3,5-Dichloro-phenyl)-5- ⁇ ' ⁇ trifluoromethyl-4,5-dihvdro-isoxazol-3-yl1-2- methyl-N-( ⁇ ? ) -2-(2,2-difluoroethyl)-3-oxo-isoxazolidin-4-yl)-benzamide
- Example 17 6-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl1-4- methyl-N-r(R)-3-oxo-2-(2,2,2-trifluoro-ethyl)-isoxazolidin-4-yl1-nicotinamide (compound C6)
- Step A 5 -Bromo-2-iodo-4-methyl -pyridine
- Step A In an oven-dried flask the compound obtained in Step A (4.67 g) was dissolved in tetrahydrofuran (22 ml). The solution was cooled to -15°C, then isopropyl magnesium bromide (17.2 ml, 15% solution in THF) was added dropwise at a rate to keep the internal temperature between -15°C to -10°C. The reaction was stirred at this temperature for 1 hour, then anhydrous dimethylformamide (1.8 ml) was added at a rate to keep the internal temperature below 0°C. The reaction was stirred at this temperature for 1 hour, then poured into water and extracted with diethyl ether. The organic layer was dried over sodium sulfate and concentrated in vacuo. The crude title aldehyde product (2.4 g, brown solid) was used as such in the next step.
- Step C 5-Bromo-4-methyl-pyridine-2-carbaldehyde oxime
- Step B To a solution of the compound obtained in Step B (3.1 g) in EtOH (47.5 ml) and water (23 ml) were added hydroxylamine hydrochloride (1.4g) and sodium acetate (1.9 g). The reaction was stirred for 15 min at room temperature. The white solid was filtered off and the solution concentrated in vacuo to afford the crude title product (2.2 g, white solid), which was used directly for the next step.
- LCMS Method F
- Step D 5-Bromo-2-r5-(3,5-dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl1-4- methyl -pyridine
- Step C To a solution of the compound obtained in Step C (2.2 g) in dimethylformamide (24 ml) was added N-chlorosuccinimide (1.4 g) in three portions at room temperature under argon. The reaction mixture was allowed to stir overnight at room temperature then a solution of l,3-dichloro-5-(l-trifluoromethyl-vinyl)-benzene (2.7 g, prepared as described in
- Step E 6-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro-isoxazol-3-yl1-4-methyl- nicotinic acid
- reaction was performed under carbon monoxide at 15 bar at room temperature for 20 min.
- the reaction mixture was then diluted in toluene and the suspension was filtered on Celite and washed with toluene.
- the solvent was removed under reduced pressure to obtain a red oil.
- the residue was purified by column chromatography (ethyl acetate, cyclohexane) to yield the butyl ester of the title product as a liquid (3.45 g).
- Step F 6-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro-isoxazol-3-yl1-4-methyl- N-r(R)-3-oxo-2-(2,2,2-trifluoro-eth l)-isoxazolidin-4-yl1-nicotinamide
- the solid (enriched in one diastereomer) was analysed by chiral HPLC (method K): 8.90 min (91.02%), 1 1.97 min (08.98%).
- the filtrate (enriched in the other diastereomer) was also analysed by chiral HPLC (method K): 8.66 min (17.50%), 11.02 min (69.38 %).
- Example 20 6-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl1-2- methyl-nicotinic acid
- This compound was prepared from 2,5-dibromo-6-methyl-pyridine following a similar route to that described in Example 17, Steps A-E.
- This compound was prepared from 5-formyl-pyridine-2-carboxylic acid methyl ester using the standard synthesis described in WO 2009/080250.
- 5-Formyl-pyridine-2-carboxylic acid methyl ester was synthesized by reductive formylation of 5-bromo-pyridine-2-carboxylic acid methyl ester using the conditions described in Angewandte Chemie, International Edition (2006), 45(1), 154-158.
- This acid was prepared from the methyl ester of 2-bromo-4-[5-(3,5-dichloro-phenyl)-5- trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-benzoic acid (Example 27) as follows: A solution of cyclopropyl boronic acid (0.67 g), 2-bromo-4-[5-(3,5-dichloro-phenyl)-5- trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-benzoic acid methyl ester (3 g) and
- Steps A-C Preparation of 2,6-Dichloro-4-(l-trifluoromethvl-vinvl)-benzonitrile
- Step D Pr aration of l-Trifluoromethoxy-3-(l-trifluoromethyl-vinyl)-benzene
- Step E Preparation of 4-r5-(3,5-Dichloro-4-cvano-phenyl)-5-trifluoromethyl-4,5-dihvdro- isoxazol-3- ⁇ -2 -methyl -benzoic acid tert-butyl ester
- N-chlorosuccinimide 832 mg
- NMS N-chlorosuccinimide
- Step F Preparation of 4-r5-(3,5-dichloro-4-cvano-phenyl)-5-trifluoromethyl-4,5-dihvdro- isoxazol-3- ⁇ -2 -methyl -benzoic acid
- Example 26 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro-isoxazol-3-yl1- benzoic acid
- This compound was prepared as described in WO 2005/085216.
- This compound was prepared as described in WO 2009/080250.
- Example 28 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro-isoxazol-3-yl1- naphthalene-l-carboxylic acid
- This compound was prepared as described in WO 2010/025998.
- Example 30 2-Methyl-4- ⁇ 5 -(3 -chloro-5 -bromo-phenv0-5 -trifluoromethyl-4,5 -dihydro- isoxazol-3-vH -benzoic acid
- This compound was prepared following a similar route to that described in Example 24.
- Step A Preparation of 4-r5-(Chloro-difluoro-methyl)-5-(3,5-dichloro-phenyl)-4,5-dihvdro- isoxazol-3- ⁇ -2 -methyl -benzoic acid tert-butyl ester
- Example 32 Preparation of (5 (4-r5-(3,5-dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro- isoxazol-3-yl1-2 -methyl -benzoylaminol -methyl-2- ⁇ - ⁇ 1 ,2,31oxathiazolidine-3-carboxylic acid carbamic acid ter-butyl ester (Compound F8)
- Step A Preparation of (3 (4-r5-(3,5-dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro- isoxazol-3-yl1-2 -methyl -benzoylaminol -2-hydroxy-propyl)-carbamic acid tert-butyl ester
- Oxalyl chloride (0.9 ml) was added dropwise to a solution of 4-[5-(3,5-dichloro-phenyl)-5- methyl-4,5-dihydro-isoxazol-3-yl]-2-methylbenzoic acid (0.9 g) in dichloromethane (20 ml) and 1 drop of ⁇ , ⁇ -dimethylformamide and stirred at room temperature under nitrogen for 6 hours. The mixture was concentrated and the residue was dissolved in acetonitrile (50 ml), treated with a solution of (3-amino-2-hydroxy-propyl)-carbamic acid ter-butyl ester (0.8 g) (J. Med. Chem.
- Step B Preparation of (5 (4-r5-(3,5-dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro- isoxazol-3-yl1-2 -methyl -benzoylamino I -methyl-2- ⁇ - ⁇ 1 ,2,31oxathiazolidine-3-carboxylic acid carbamic acid tert-butyl ester
- Step B Preparation of 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro-isoxazol- 3-yl1-2-methyl-N-(2-oxo-ri,2,31oxathiazolidin-5-ylmethyl)-benzamide
- Step B Preparation of 4-r5-(3,5-dichloro-phenyl)-5-methyl-4,5-dihvdro-isoxazol-3-yl1-N- (l-methyl-3-oxo-pyrazolodin-4-yl)-benzamide
- Oxalyl chloride (0.18 ml) was added dropwise to a solution of 4-[5-(3,5-dichloro-phenyl)-5- methyl-4,5-dihydro-isoxazol-3-yl]-2-methylbenzoic acid (0.398 g) in dichloromethane (10 ml) and 1 drop of ⁇ , ⁇ -dimethylformamide and stirred at room temperature under nitrogen for 6 hours.
- reaction mixture was concentrated and purified by chromatography on silica gel (eluent hexane/ethyl acetate 60:40) to give 4-[5-(3,5-dichloro-phenyl)-5-methyl-4,5-dihydro- isoxazol-3-yl]-N-(l-methyl-3-oxo-pyrazolodin-4-yl)-benzamide as a solid compound which is a mixture of diasteromers (5 mg).
- Step A 4-Acetyl-N-((R)-2-ethyl-3-oxo-isoxazolidin-4-yl)-2-methyl-benzamide
- Example 37 Asymmetric preparation of 4-r5-(3,5-dichloro-phenyl)-5-trifluoromethyl-4,5- dihydro-isoxazol-3-yll -2 -methyl -N-((R)-2-ethyl-3-oxo-isoxazolidin-4-yl)-benzamide Step A: Catalyst preparation: 2,3,4,5,6-pentafluorophenyl-methyl quininium bromide
- Step B 4-r5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihvdro-isoxazol-3-yl1-2-methyl-
- Cotton leaf discs were placed on agar in a 24-well microtiter plate and sprayed with test solutions at an application rate of 200 ppm. After drying, the leaf discs were infested with 5 LI larvae. The samples were checked for mortality, feeding behavior, and growth regulation 3 days after treatment (DAT).
- Eggs (0-24 h old) were placed in 24-well microtiter plate on artificial diet and treated with test solutions at an application rate of 200 ppm (concentration in well 18 ppm) by pipetting. After an incubation period of 4 days, samples were checked for egg mortality, larval mortality, and growth regulation.
- MTP microtiter plate
- Diabrotica balteata (Corn root worm):
- MTP microtiter plate
- test solutions at an application rate of 200 ppm (concentration in well 18 ppm) by pipetting. After drying, the MTP's were infested with L2 larvae (6-10 per well). After an incubation period of 5 days, samples were checked for larval mortality and growth regulation.
- Myzus persicae Green peach aphid
- systemic test Roots of pea seedlings, infested with an aphid population of mixed ages, are placed directly in the test solutions at an application rate of 12.5 ppm. 6 days after introduction, samples are checked for mortality and special effects on the plant. The following compounds gave at least 80%> control of Myzus persicae:
- Thrips tabaci Onion thrips
- Sunflower leaf discs were placed on agar in a 24-well microtiter plate and sprayed with test solutions at an application rate of 200 ppm. After drying, the leaf discs were infested with an aphid population of mixed ages. After an incubation period of 7 days, samples were checked for mortality.
- Tetranychus urticae (Two-spotted spider mite):
- Bean leaf discs on agar in 24-well microtiter plates were sprayed with test solutions at an application rate of 200 ppm. After drying, the leaf discs are infested with mite populations of mixed ages. 8 days later, discs are checked for egg mortality, larval mortality, and adult mortality.
Abstract
Description
Claims
Priority Applications (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201207701A UA109645C2 (en) | 2009-12-01 | 2010-01-12 | INSECTICID COMPOUNDS BASED ON ISOXASOLINE DERIVATIVES |
KR1020127014101A KR101771199B1 (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives |
EA201200826A EA022114B1 (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives |
BR112012013085-4A BR112012013085B1 (en) | 2009-12-01 | 2010-12-01 | INSECTICID COMPOUNDS BASED ON ISOXAZOLINE DERIVATIVES, COMPOSITION, COMBINATION PRODUCT, WELL AS A METHOD TO COMBAT AND CONTROL PEST |
AU2010326766A AU2010326766C1 (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives |
US13/512,820 US8735362B2 (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives |
JP2012541480A JP5980119B2 (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives |
CN201080054495.6A CN102639529B (en) | 2009-12-01 | 2010-12-01 | Based on the Pesticidal compound of isoxazoline derivative |
LTEP10787393.7T LT2507230T (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives |
CA2780522A CA2780522C (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives |
MX2012006171A MX2012006171A (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives. |
PL10787393T PL2507230T3 (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives |
AP2012006285A AP2012006285A0 (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives. |
ES10787393.7T ES2666415T3 (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives |
EP10787393.7A EP2507230B1 (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives |
DK10787393.7T DK2507230T3 (en) | 2009-12-01 | 2010-12-01 | Insecticide compounds based on isoxazoline derivatives |
NZ600036A NZ600036A (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives |
ZA2012/03587A ZA201203587B (en) | 2009-12-01 | 2012-05-16 | Insecticidal compounds based on isoxazoline derivatives |
IL219912A IL219912A (en) | 2009-12-01 | 2012-05-21 | Isoxazoline derivatives, their use as pesticides and compositions comprising them |
TNP2012000276A TN2012000276A1 (en) | 2009-12-01 | 2012-05-30 | Insecticidal compounds based on isoxazoline derivatives |
MA34920A MA33782B1 (en) | 2009-12-01 | 2012-05-31 | INSECTICIDE COMPOUNDS BASED ON ISOXAZOLINE DERIVATIVES |
US14/258,079 US9609869B2 (en) | 2009-12-01 | 2014-04-22 | Insecticidal compounds based on isoxazoline derivatives |
US15/429,631 US10206400B2 (en) | 2009-12-01 | 2017-02-10 | Insecticidal compounds based on isoxazoline derivatives |
US16/267,562 US10750745B2 (en) | 2009-12-01 | 2019-02-05 | Insecticidal compounds based on isoxazoline derivatives |
US17/000,978 US11357231B2 (en) | 2009-12-01 | 2020-08-24 | Insecticidal compounds based on isoxazoline derivatives |
US17/839,058 US20230000082A1 (en) | 2009-12-01 | 2022-06-13 | Agrochemical compounds |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09177640 | 2009-12-01 | ||
EP09177640.1 | 2009-12-01 | ||
EP10186537 | 2010-10-05 | ||
EP10186537.6 | 2010-10-05 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/512,820 A-371-Of-International US8735362B2 (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives |
US14/258,079 Continuation US9609869B2 (en) | 2009-12-01 | 2014-04-22 | Insecticidal compounds based on isoxazoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011067272A1 true WO2011067272A1 (en) | 2011-06-09 |
Family
ID=43447698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2010/068605 WO2011067272A1 (en) | 2009-12-01 | 2010-12-01 | Insecticidal compounds based on isoxazoline derivatives |
Country Status (34)
Country | Link |
---|---|
US (5) | US8735362B2 (en) |
EP (1) | EP2507230B1 (en) |
JP (1) | JP5980119B2 (en) |
KR (1) | KR101771199B1 (en) |
CN (1) | CN102639529B (en) |
AP (1) | AP2012006285A0 (en) |
AR (2) | AR079224A1 (en) |
AU (1) | AU2010326766C1 (en) |
BR (1) | BR112012013085B1 (en) |
CA (1) | CA2780522C (en) |
CL (1) | CL2012001430A1 (en) |
CO (1) | CO6541622A2 (en) |
CR (1) | CR20120299A (en) |
DK (1) | DK2507230T3 (en) |
EA (1) | EA022114B1 (en) |
EC (1) | ECSP12011940A (en) |
ES (1) | ES2666415T3 (en) |
GE (1) | GEP20146161B (en) |
HU (1) | HUE036528T2 (en) |
IL (1) | IL219912A (en) |
LT (1) | LT2507230T (en) |
MA (1) | MA33782B1 (en) |
MX (1) | MX2012006171A (en) |
MY (1) | MY157849A (en) |
NI (1) | NI201200098A (en) |
NZ (1) | NZ600036A (en) |
PL (1) | PL2507230T3 (en) |
PT (1) | PT2507230T (en) |
SA (1) | SA110310884B1 (en) |
TN (1) | TN2012000276A1 (en) |
TW (1) | TWI487486B (en) |
UY (1) | UY33070A (en) |
WO (1) | WO2011067272A1 (en) |
ZA (1) | ZA201203587B (en) |
Cited By (124)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011104089A1 (en) * | 2010-02-25 | 2011-09-01 | Syngenta Participations Ag | Process for the preparation of isoxazoline derivatives |
WO2012067235A1 (en) * | 2010-11-19 | 2012-05-24 | 日産化学工業株式会社 | Control agent against parasite and sanitary insect |
WO2012163945A1 (en) * | 2011-05-31 | 2012-12-06 | Syngenta Participations Ag | Pesticidal mixtures comprising isoxazoline derivatives |
WO2012163948A1 (en) * | 2011-05-31 | 2012-12-06 | Syngenta Participations Ag | Pesticidal mixtures including isoxazoline derivatives |
WO2012163960A1 (en) * | 2011-05-31 | 2012-12-06 | Syngenta Participations Ag | Pesticidal mixtures including isoxazoline derivatives |
WO2013026930A1 (en) | 2011-08-25 | 2013-02-28 | Syngenta Participations Ag | Process for the preparation of thietane derivatives |
WO2013050302A1 (en) | 2011-10-03 | 2013-04-11 | Syngenta Participations Ag | Isoxazoline derivatives as insecticidal compounds |
CN103562189A (en) * | 2011-05-31 | 2014-02-05 | 先正达参股股份有限公司 | Insecticidal compounds |
WO2014019950A1 (en) | 2012-08-03 | 2014-02-06 | Syngenta Participations Ag | Methods of pest control in soybean |
WO2014029639A1 (en) | 2012-08-24 | 2014-02-27 | Syngenta Participations Ag | Methods of soil pest control |
WO2014029709A1 (en) | 2012-08-24 | 2014-02-27 | Syngenta Participations Ag | Methods of controlling insects |
WO2014029640A1 (en) | 2012-08-24 | 2014-02-27 | Syngenta Participations Ag | Methods of controlling insects |
JP2015502967A (en) * | 2011-12-23 | 2015-01-29 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | Isothiazoline compounds for combating invertebrate pests |
JPWO2013069731A1 (en) * | 2011-11-08 | 2015-04-02 | 日産化学工業株式会社 | Catalytic asymmetric synthesis method of optically active isoxazoline compound and optically active isoxazoline compound |
US9029409B2 (en) | 2011-04-30 | 2015-05-12 | Abbvie Inc. | Isoxazolines as therapeutic agents |
JP2015514103A (en) * | 2012-04-04 | 2015-05-18 | インターベット インターナショナル ベー. フェー. | Soft chewable pharmaceutical products |
US9180121B2 (en) | 2011-09-12 | 2015-11-10 | Merial, Inc. | Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof |
US9233100B2 (en) | 2012-02-06 | 2016-01-12 | Merial, Inc. | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof |
WO2016023787A1 (en) * | 2014-08-11 | 2016-02-18 | Syngenta Participations Ag | Process for the preparation of optically active isoxazoline compounds |
US9340509B2 (en) | 2013-12-02 | 2016-05-17 | Chemocentryx, Inc. | CCR6 compounds |
WO2017050922A1 (en) | 2015-09-23 | 2017-03-30 | Syngenta Participations Ag | Isoxazoline-substituted benzamides and analogues as insecticides |
WO2017050921A1 (en) * | 2015-09-23 | 2017-03-30 | Syngenta Participations Ag | Isoxazoline-substituted benzamides and analogues as insecticides |
JPWO2016017467A1 (en) * | 2014-07-28 | 2017-04-27 | 住友化学株式会社 | Amide compounds and their use for controlling harmful arthropods |
WO2017102006A1 (en) | 2015-12-17 | 2017-06-22 | Syngenta Participations Ag | Microbiocidal oxadiazole derivatives |
WO2017140614A1 (en) | 2016-02-19 | 2017-08-24 | Basf Se | Method for controlling pests of soybean, corn, and cotton plants |
EP3178323A4 (en) * | 2014-07-29 | 2018-02-07 | Sumitomo Chemical Company, Limited | Noxious arthropod control agent containing amide compound |
WO2018039508A1 (en) * | 2016-08-25 | 2018-03-01 | Merial, Inc. | Method for reducing unwanted effects in parasiticidal treatments |
US9968087B2 (en) | 2014-02-26 | 2018-05-15 | Basf Se | Azoline compounds |
EP3336086A1 (en) | 2016-12-19 | 2018-06-20 | Syngenta Participations Ag | Pesticidally active azetidine sulfone amide isoxazoline derivatives |
EP3336087A1 (en) | 2016-12-19 | 2018-06-20 | Syngenta Participations Ag | Pesticidally active azetidine sulfone amide isoxazoline derivatives |
WO2018139560A1 (en) | 2017-01-26 | 2018-08-02 | 三井化学アグロ株式会社 | Pyridone compound and bactericide for agricultural and horticultural use, which uses said compound as active ingredient |
WO2018172477A1 (en) | 2017-03-23 | 2018-09-27 | Syngenta Participations Ag | Insecticidal compounds |
WO2018172480A1 (en) | 2017-03-23 | 2018-09-27 | Syngenta Participations Ag | Insecticidal compounds |
WO2018172471A1 (en) | 2017-03-22 | 2018-09-27 | Syngenta Participations Ag | Pesticidally active cyclopropyl methyl amide derivatives |
US10085448B2 (en) | 2014-12-22 | 2018-10-02 | Basf Se | Azoline compounds substituted by a carbocyclic condensed ring system |
US10093662B2 (en) | 2014-12-22 | 2018-10-09 | Basf Se | Azoline compounds substituted by a condensed ring system |
WO2018190352A1 (en) | 2017-04-11 | 2018-10-18 | 三井化学アグロ株式会社 | Pyridone compound, and agricultural and horticultural fungicide having this as active component |
WO2018190350A1 (en) | 2017-04-10 | 2018-10-18 | 三井化学アグロ株式会社 | Pyridone compound, and agricultural and horticultural fungicide having this as active component |
WO2018190351A1 (en) | 2017-04-10 | 2018-10-18 | 三井化学アグロ株式会社 | Pyridone compound, and agricultural and horticultural fungicide having this as active component |
WO2018225829A1 (en) | 2017-06-08 | 2018-12-13 | 三井化学アグロ株式会社 | Pyridone compound and agricultural and horticultural fungicide |
WO2018234478A1 (en) * | 2017-06-23 | 2018-12-27 | Basf Se | Pesticidal mixtures comprising a pyrazole compound |
WO2019105871A1 (en) | 2017-11-29 | 2019-06-06 | Bayer Aktiengesellschaft | Nitrogenous heterocycles as a pesticide |
WO2019121394A1 (en) | 2017-12-19 | 2019-06-27 | Syngenta Participations Ag | Polymorphs |
US10375961B2 (en) | 2012-02-27 | 2019-08-13 | Bayer Intellectual Property Gmbh | Active compound combinations containing a thiazoylisoxazoline and a fungicide |
WO2019170626A1 (en) | 2018-03-08 | 2019-09-12 | Bayer Aktiengesellschaft | Use of heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides in plant protection |
EP3545764A1 (en) | 2019-02-12 | 2019-10-02 | Bayer AG | Crystal form of 2-({2-fluoro-4-methyl-5-[(r)-(2,2,2-trifluoroethyl)sulfinyl]phenyl}imino)-3-(2,2,2- trifluoroethyl)-1,3-thiazolidin-4-one |
US10433552B2 (en) | 2016-04-06 | 2019-10-08 | Merial, Inc. | Process for the preparation of isoxazoline compounds |
WO2019197468A1 (en) | 2018-04-12 | 2019-10-17 | Bayer Aktiengesellschaft | N-(cyclopropylmethyl)-5-(methylsulfonyl)-n-{1-[1-(pyrimidin-2-yl)-1h-1,2,4-triazol-5-yl]ethyl}benzamide derivatives and the corresponding pyridine-carboxamide derivatives as pesticides |
WO2019206799A1 (en) | 2018-04-25 | 2019-10-31 | Bayer Aktiengesellschaft | Novel heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides |
EP3564225A1 (en) | 2019-03-21 | 2019-11-06 | Bayer Aktiengesellschaft | Crystalline form of spiromesifen |
WO2019243263A1 (en) | 2018-06-19 | 2019-12-26 | Syngenta Participations Ag | Insecticidal compounds |
WO2019243256A1 (en) | 2018-06-19 | 2019-12-26 | Syngenta Crop Protection Ag | Pesticidally active isoxazoline derivatives containing an amide group and an azetidine sulfone group |
WO2019243262A1 (en) | 2018-06-19 | 2019-12-26 | Syngenta Crop Protection Ag | Pesticidally active azetidine sulfones amide isoxazoline derivatives |
WO2019243253A1 (en) | 2018-06-19 | 2019-12-26 | Syngenta Crop Protection Ag | Pesticidally active isoxazoline derivatives containing an amide group and an azetidine sulfone group |
EP3586630A1 (en) | 2018-06-28 | 2020-01-01 | Bayer AG | Active compound combinations having insecticidal/acaricidal properties |
WO2020022412A1 (en) | 2018-07-25 | 2020-01-30 | 三井化学アグロ株式会社 | Pyridone compound and agricultural and horticultural fungicide having this as active component |
EP3608311A1 (en) | 2019-06-28 | 2020-02-12 | Bayer AG | Crystalline form a of n-[4-chloro-3-[(1-cyanocyclopropyl)carbamoyl]phenyl]-2-methyl-4-methylsulfonyl-5-(1,1,2,2,2-pentafluoroethyl)pyrazole-3-carboxamide |
US20200045971A1 (en) * | 2016-10-10 | 2020-02-13 | Basf Se | Pesticidal mixtures |
WO2020043650A1 (en) | 2018-08-29 | 2020-03-05 | Bayer Aktiengesellschaft | Active compound combinations having insecticidal/acaricidal properties |
WO2020064564A1 (en) | 2018-09-26 | 2020-04-02 | Syngenta Participations Ag | Insecticidal compounds |
WO2020064560A1 (en) | 2018-09-26 | 2020-04-02 | Syngenta Crop Protection Ag | Pesticidally active cyclopropyl methyl amide derivatives |
WO2020064565A1 (en) | 2018-09-26 | 2020-04-02 | Syngenta Crop Protection Ag | Insecticidal compounds |
WO2020064569A1 (en) | 2018-09-26 | 2020-04-02 | Syngenta Crop Protection Ag | Insecticidal compounds |
EP3636644A1 (en) | 2018-10-11 | 2020-04-15 | Bayer Aktiengesellschaft | Mesoionic imidazopyridines as insecticides |
WO2020078839A1 (en) | 2018-10-16 | 2020-04-23 | Bayer Aktiengesellschaft | Active substance combinations |
WO2020088949A1 (en) | 2018-10-29 | 2020-05-07 | Basf Se | Process for preparation of optically enriched aldol compounds |
WO2020094434A1 (en) | 2018-11-06 | 2020-05-14 | Basf Se | Process for preparation of optically enriched isoxazolines |
WO2020114813A1 (en) | 2018-12-04 | 2020-06-11 | Basf Se | Process for preparation of 5-bromo-1,3-dichloro-2-fluoro-benzene |
WO2020114934A1 (en) | 2018-12-07 | 2020-06-11 | Bayer Aktiengesellschaft | Herbicide compositions |
WO2020114932A1 (en) | 2018-12-07 | 2020-06-11 | Bayer Aktiengesellschaft | Herbicidal compositions |
WO2020127878A1 (en) * | 2018-12-21 | 2020-06-25 | Intervet International B.V. | Method for producing (5s)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4h-isoxazol-3-yl]-2-methyl-benzoic acid |
EP3696177A1 (en) | 2019-02-12 | 2020-08-19 | Basf Se | Heterocyclic compounds for the control of invertebrate pests |
EP3701796A1 (en) | 2019-08-08 | 2020-09-02 | Bayer AG | Active compound combinations |
WO2020173860A1 (en) | 2019-02-26 | 2020-09-03 | Bayer Aktiengesellschaft | Fused bicyclic heterocycle derivatives as pesticides |
WO2020173861A1 (en) | 2019-02-26 | 2020-09-03 | Bayer Aktiengesellschaft | Condensed bicyclic heterocyclic derivatives as pest control agents |
EP3725788A1 (en) | 2019-04-15 | 2020-10-21 | Bayer AG | Novel heteroaryl-substituted aminoalkyl azole compounds as pesticides |
WO2020225439A1 (en) | 2019-05-08 | 2020-11-12 | Bayer Aktiengesellschaft | Ulv formulations with enhanced rainfastness |
WO2020225242A1 (en) | 2019-05-08 | 2020-11-12 | Bayer Aktiengesellschaft | Active compound combination |
WO2020229398A1 (en) | 2019-05-14 | 2020-11-19 | Bayer Aktiengesellschaft | (1-alkenyl)-substituted pyrazoles and triazoles as pest control agents |
EP3750888A1 (en) | 2019-06-12 | 2020-12-16 | Bayer Aktiengesellschaft | Crystalline form a of 1,4-dimethyl-2-[2-(pyridin-3-yl)-2h-indazol-5-yl]-1,2,4-triazolidine-3,5-dione |
WO2020263812A1 (en) | 2019-06-24 | 2020-12-30 | Auburn University | A bacillus strain and methods of its use for plant growth promotion |
WO2021001273A1 (en) | 2019-07-04 | 2021-01-07 | Bayer Aktiengesellschaft | Herbicidal compositions |
WO2021000865A1 (en) | 2019-07-01 | 2021-01-07 | 沈阳化工大学 | Isoxazoline compound, preparation method therefor and application thereof |
EP3771714A1 (en) | 2019-07-30 | 2021-02-03 | Bayer AG | Nitrogen-containing heterocycles as pesticides |
WO2021058659A1 (en) | 2019-09-26 | 2021-04-01 | Bayer Aktiengesellschaft | Rnai-mediated pest control |
WO2021069575A1 (en) | 2019-10-11 | 2021-04-15 | Bayer Animal Health Gmbh | Heteroaryl-substituted pyrazine derivatives as pesticides |
WO2021089673A1 (en) | 2019-11-07 | 2021-05-14 | Bayer Aktiengesellschaft | Substituted sulfonyl amides for controlling animal pests |
WO2021097162A1 (en) | 2019-11-13 | 2021-05-20 | Bayer Cropscience Lp | Beneficial combinations with paenibacillus |
EP3845304A1 (en) | 2019-12-30 | 2021-07-07 | Bayer AG | Capsule suspension concentrates based on polyisocyanates and biodegradable amine based cross-linker |
EP3868207A1 (en) | 2020-02-24 | 2021-08-25 | Bayer Aktiengesellschaft | Encapsulated pyrethroids with improved activity in soil and leaf applications |
WO2021165195A1 (en) | 2020-02-18 | 2021-08-26 | Bayer Aktiengesellschaft | Heteroaryl-triazole compounds as pesticides |
WO2021260017A1 (en) | 2020-06-26 | 2021-12-30 | Bayer Aktiengesellschaft | Aqueous capsule suspension concentrates comprising biodegradable ester groups |
WO2022022221A1 (en) * | 2020-07-30 | 2022-02-03 | 山东省联合农药工业有限公司 | Isoxazoline-substituted benzamide derivative, and preparation method therefor and use thereof |
EP3994985A1 (en) | 2020-11-08 | 2022-05-11 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift properties |
EP3994989A1 (en) | 2020-11-08 | 2022-05-11 | Bayer AG | Agrochemical composition with improved drift, rainfastness and uptake properties |
EP3994986A1 (en) | 2020-11-08 | 2022-05-11 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift and spreading properties |
EP3994992A1 (en) | 2020-11-08 | 2022-05-11 | Bayer AG | Low drift, rainfastness, high uptake and ulv tank mix adjuvant formulation |
EP3994988A1 (en) | 2020-11-08 | 2022-05-11 | Bayer AG | Agrochemical composition with improved drift, spreading and rainfastness properties |
EP3994991A1 (en) | 2020-11-08 | 2022-05-11 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift, spreading, uptake and rainfastness properties |
EP3994994A1 (en) | 2020-11-08 | 2022-05-11 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading, high uptake and ulv tank mix adjuvant formulation |
EP3994990A1 (en) | 2020-11-08 | 2022-05-11 | Bayer AG | Agrochemical composition with improved drift, spreading and uptake properties |
EP3994987A1 (en) | 2020-11-08 | 2022-05-11 | Bayer AG | Agrochemical composition with improved drift and uptake properties |
EP3994993A1 (en) | 2020-11-08 | 2022-05-11 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading and ulv tank mix adjuvant formulation |
EP3994995A1 (en) | 2020-11-08 | 2022-05-11 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading, high uptake and ulv tank mix adjuvant formulation |
WO2022152728A1 (en) | 2021-01-15 | 2022-07-21 | Bayer Aktiengesellschaft | Herbicidal compositions |
EP4043444A1 (en) | 2021-02-11 | 2022-08-17 | Basf Se | Substituted isoxazoline derivatives |
WO2022171472A1 (en) | 2021-02-11 | 2022-08-18 | Basf Se | Substituted isoxazoline derivatives |
WO2022207887A1 (en) | 2021-03-31 | 2022-10-06 | Syngenta Crop Protection Ag | Insect pest bait composition with isocycloseram and method for controlling insect pests |
WO2022238575A1 (en) | 2021-05-14 | 2022-11-17 | Syngenta Crop Protection Ag | Insect, acarina and nematode pest control |
WO2022238576A1 (en) | 2021-05-14 | 2022-11-17 | Syngenta Crop Protection Ag | Seed treatment compositions |
WO2022238194A1 (en) | 2021-05-10 | 2022-11-17 | Bayer Aktiengesellschaft | Herbicide/safener combination based on safeners from the class of substituted [(1,5-diphenyl-1h-1,2,4-triazol-3-yl)oxy]acetic acids and their salts |
US11548859B2 (en) | 2018-12-21 | 2023-01-10 | Intervet Inc. | Method for producing (5,S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4Hisoxazol-3-yl]-2-methyl-benzoic acid |
WO2023031061A1 (en) | 2021-08-30 | 2023-03-09 | Syngenta Crop Protection Ag | Process for the preparation of an optically active isoxazoline compound |
KR102559251B1 (en) * | 2023-05-19 | 2023-07-24 | 전준형 | Control method using composition for pest control |
EP4265110A1 (en) | 2022-04-20 | 2023-10-25 | Bayer AG | Water dispersible granules with low melting active ingredients prepared by extrusion |
WO2023202966A1 (en) | 2022-04-21 | 2023-10-26 | Syngenta Crop Protection Ag | Pesticidal compositions including an isoxazoline compound |
WO2023217619A1 (en) | 2022-05-07 | 2023-11-16 | Bayer Aktiengesellschaft | Low drift aqueous liquid formulations for low, medium, and high spray volume application |
WO2023222724A1 (en) | 2022-05-16 | 2023-11-23 | Syngenta Crop Protection Ag | Method for mosquito control |
WO2023232560A1 (en) | 2022-05-30 | 2023-12-07 | Syngenta Crop Protection Ag | Process for the preparation of 4-substituted 2-oxazolidinones |
WO2024013015A1 (en) | 2022-07-11 | 2024-01-18 | Bayer Aktiengesellschaft | Herbicidal compositions |
WO2024013016A1 (en) | 2022-07-11 | 2024-01-18 | Bayer Aktiengesellschaft | Herbicidal compositions |
WO2024033374A1 (en) | 2022-08-11 | 2024-02-15 | Syngenta Crop Protection Ag | Novel arylcarboxamide or arylthioamide compounds |
WO2024068473A1 (en) | 2022-09-27 | 2024-04-04 | Bayer Aktiengesellschaft | Herbicide/safener combination based on safeners from the class of substituted [(1,5-diphenyl-1h-1,2,4-triazol-3-yl)oxy]acetic acids and their salts |
EP4353082A1 (en) | 2022-10-14 | 2024-04-17 | Bayer Aktiengesellschaft | Herbicidal compositions |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013026939A1 (en) * | 2011-08-25 | 2013-02-28 | Syngenta Participations Ag | Methods for the control of termites and ants |
JO3626B1 (en) | 2012-02-23 | 2020-08-27 | Merial Inc | Topical compositions comprising fipronil and permethrin and methods of use |
NZ708588A (en) | 2012-11-19 | 2019-03-29 | Arch Wood Protection Inc | Succinate dehydrogenase inhibitor containing compositions |
EP3063144B1 (en) | 2013-11-01 | 2021-09-08 | Boehringer Ingelheim Animal Health USA Inc. | Antiparasitic and pesticidal isoxazoline compounds |
WO2015115488A1 (en) * | 2014-01-31 | 2015-08-06 | 日産化学工業株式会社 | Liquid pesticide composition |
US10857121B2 (en) | 2014-04-17 | 2020-12-08 | Merial Inc. | Use of malononitrile compounds for protecting animals from parasites |
JP6523334B2 (en) * | 2014-04-30 | 2019-05-29 | シンジェンタ パーティシペーションズ アーゲー | Method for the preparation of substituted cycloserines |
UY36570A (en) | 2015-02-26 | 2016-10-31 | Merial Inc | INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES OF THE SAME |
CN107835818B (en) | 2015-05-20 | 2022-04-29 | 勃林格殷格翰动物保健美国公司 | Anthelmintic depsipeptide compounds |
AU2017287716B2 (en) * | 2016-06-27 | 2019-08-08 | Korea Research Institute Of Chemical Technology | Pyridine-based compound including isoxazoline ring, and use thereof as herbicide |
US10653144B2 (en) | 2016-10-14 | 2020-05-19 | Boehringer Ingelheim Animal Health USA Inc. | Pesticidal and parasiticidal vinyl isoxazoline compounds |
CN110167921A (en) | 2016-11-16 | 2019-08-23 | 勃林格殷格翰动物保健美国公司 | Dehelminthization depsipeptide compound |
JP2020530850A (en) | 2017-08-14 | 2020-10-29 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | Pesticides and parasites Pyrazole-isoxazoline compounds |
CN111295376A (en) | 2017-11-07 | 2020-06-16 | 英特维特国际股份有限公司 | Injectable isoxazoline pharmaceutical compositions and their use against parasite infestations |
BR112020008848A2 (en) | 2017-11-07 | 2020-10-20 | Intervet International B.V. | process of preparing large isoxazoline particles |
TWI812673B (en) * | 2018-02-12 | 2023-08-21 | 美商富曼西公司 | Naphthalene isoxazoline compounds for controlling invertebrate pests |
EA202092882A1 (en) | 2018-06-08 | 2021-04-19 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | COMPOUNDS WITH PESTICIDAL EFFECT AND ALSO COMPOSITIONS AND RELATED METHODS |
AU2019301510A1 (en) | 2018-07-09 | 2021-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anthelminthic heterocyclic compounds |
CN113260419A (en) | 2018-11-20 | 2021-08-13 | 勃林格殷格翰动物保健美国公司 | Indazolyl cyanoethylamino compounds, compositions thereof, methods of making the same, and methods of using the same |
EP3941587A1 (en) | 2019-03-19 | 2022-01-26 | Boehringer Ingelheim Animal Health USA Inc. | Anthelmintic aza-benzothiophene and aza-benzofuran compounds |
PE20220173A1 (en) | 2019-05-03 | 2022-01-28 | Intervet Int Bv | INJECTABLE PHARMACEUTICAL COMPOSITIONS AND THEIR USES |
EP4077286A1 (en) * | 2019-12-18 | 2022-10-26 | Elanco Tiergesundheit AG | Isoxazoline derivatives as pesticides |
JP7447315B2 (en) | 2020-05-20 | 2024-03-11 | インターベット インターナショナル ベー. フェー. | Injectable pharmaceutical compositions and uses thereof |
CA3183100A1 (en) | 2020-05-29 | 2021-12-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anthelmintic heterocyclic compounds |
CN114315747A (en) * | 2020-09-30 | 2022-04-12 | 山东润博生物科技有限公司 | Preparation method of 5, 5-dimethyl isoxazolidine-3-thioketone |
US20240116854A1 (en) | 2021-01-27 | 2024-04-11 | Intervet Inc. | Cyclopropylamide compounds against parasites in fish |
WO2022162016A1 (en) | 2021-01-27 | 2022-08-04 | Intervet International B.V. | Cyclopropylamide compounds against parasites in fish |
CA3224226A1 (en) * | 2021-06-25 | 2022-12-29 | In The Bowl Animal Health, Inc. | Oral feline feed and methods for controlling tick infestations in a feline |
WO2023112988A1 (en) * | 2021-12-16 | 2023-06-22 | 住友化学株式会社 | Method for controlling noxious arthropods |
US20230312207A1 (en) | 2022-02-17 | 2023-10-05 | Boehringer Ingelheim Vetmedica Gmbh | Method and system for providing a fluid product mailer |
CN117126116A (en) * | 2022-05-20 | 2023-11-28 | 天津瑞普生物技术股份有限公司 | Derivative of isoxazoline compound and application thereof |
CN115073369A (en) * | 2022-05-31 | 2022-09-20 | 汉瑞药业(荆门)有限公司 | Preparation method of 5-bromoquinoline-8-formaldehyde |
Citations (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4639771A (en) | 1984-10-31 | 1987-01-27 | Kabushiki Kaisha Toshiba | Image processing system |
EP0357460A2 (en) | 1988-09-02 | 1990-03-07 | Sankyo Company Limited | 13-Substituted milbemycin derivatives, their preparation and use |
EP0382173A2 (en) | 1989-02-07 | 1990-08-16 | Meiji Seika Kaisha Ltd. | PF 1022 substance, method of producing same and anthelmintic composition containing same |
US5015630A (en) | 1989-01-19 | 1991-05-14 | Merck & Co., Inc. | 5-oxime avermectin derivatives |
EP0444964A1 (en) | 1990-03-01 | 1991-09-04 | Sankyo Company Limited | Milbemycin ether derivatives, their preparation and their anthelmintic uses |
EP0503538A1 (en) | 1991-03-08 | 1992-09-16 | Meiji Seika Kaisha Ltd. | Medicinal composition containing an anthelmintic cyclic depsipeptide |
WO1993019053A1 (en) | 1992-03-17 | 1993-09-30 | Fujisawa Pharmaceutical Co., Ltd. | Depsipeptide derivative, production thereof and use thereof |
WO1993025543A2 (en) | 1992-06-11 | 1993-12-23 | Bayer Aktiengesellschaft | Enniatines and enniatine derivates used to control endoparasites |
EP0594291A1 (en) | 1992-09-01 | 1994-04-27 | Sankyo Company Limited | Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor |
WO1994015944A1 (en) | 1993-01-18 | 1994-07-21 | Pfizer Limited | New antiparasitic agents related to the milbemycins and avermectins |
WO1994019334A1 (en) | 1993-02-19 | 1994-09-01 | Meiji Seika Kaisha, Ltd. | Pf1022 derivative, cyclic depsipeptide |
EP0626375A1 (en) | 1993-05-26 | 1994-11-30 | Bayer Ag | Octacyclodepsipeptides having endoparasiticidal activity |
WO1995019363A1 (en) | 1994-01-14 | 1995-07-20 | Pfizer Inc. | Antiparasitic pyrrolobenzoxazine compounds |
WO1995022552A1 (en) | 1994-02-16 | 1995-08-24 | Pfizer Limited | Antiparasitic agents |
US5478855A (en) | 1992-04-28 | 1995-12-26 | Yashima Chemical Industry Co., Ltd. | 2-(2,6-difluorophenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-oxazoline |
WO1996011945A2 (en) | 1994-10-18 | 1996-04-25 | Bayer Aktiengesellschaft | Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process |
WO1996015121A1 (en) | 1994-11-10 | 1996-05-23 | Bayer Aktiengesellschaft | Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production |
DE19520936A1 (en) | 1995-06-08 | 1996-12-12 | Bayer Ag | Ectoparasiticides means |
WO2003024222A1 (en) | 2001-09-21 | 2003-03-27 | E. I. Du Pont De Nemours And Company | Anthranilamide arthropodicide treatment |
WO2004072086A2 (en) | 2003-02-14 | 2004-08-26 | Pfizer Limited | Antiparasitic terpene alkaloids |
WO2005085216A1 (en) | 2004-03-05 | 2005-09-15 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and noxious organism control agent |
JP2007008914A (en) | 2004-10-27 | 2007-01-18 | Nissan Chem Ind Ltd | Substituted diamine compound and agricultural and horticultural bactericide |
JP2007016017A (en) | 2005-06-06 | 2007-01-25 | Nissan Chem Ind Ltd | Substituted isoxazoline compound and pest control agent |
WO2007026965A1 (en) | 2005-09-02 | 2007-03-08 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and harmful organism-controlling agent |
JP2007106756A (en) | 2005-09-14 | 2007-04-26 | Nissan Chem Ind Ltd | Substituted isoxazoline compound and pesticide |
WO2007070606A2 (en) | 2005-12-14 | 2007-06-21 | E. I. Du Pont De Nemours And Company | Isoxazolines for controlling invertebrate pests |
WO2007074789A1 (en) | 2005-12-26 | 2007-07-05 | Nissan Chemical Industries, Ltd. | 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof |
WO2007075459A2 (en) | 2005-12-16 | 2007-07-05 | E. I. Du Pont De Nemours And Company | 5-aryl isoxazolines for controlling invertebrate pests |
DE102006015467A1 (en) | 2006-03-31 | 2007-10-04 | Bayer Cropscience Ag | New cyclic enamine ketone derivatives useful for controlling pests, especially insects |
WO2009001942A1 (en) | 2007-06-27 | 2008-12-31 | Nissan Chemical Industries, Ltd. | Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound, and method for production of isoxazoline compound |
WO2009080250A2 (en) | 2007-12-24 | 2009-07-02 | Syngenta Participations Ag | Insecticidal compounds |
WO2010025998A1 (en) | 2008-09-04 | 2010-03-11 | Syngenta Participations Ag | Insecticidal compounds |
WO2010086225A1 (en) * | 2009-01-29 | 2010-08-05 | Syngenta Participations Ag | Insecticidal compounds |
Family Cites Families (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2845432A (en) * | 1954-12-23 | 1958-07-29 | Merck & Co Inc | Benzamido and acetamido 4-amino-3-isoxazolidones and alkylated derivatives |
US2840565A (en) * | 1954-12-23 | 1958-06-24 | Merck & Co Inc | Optical isomers of 4-amino-3-isoxazolidone |
US2929836A (en) * | 1956-07-13 | 1960-03-22 | Piero M Carrara | Preparation of certain hydroxamic acids |
US5153193A (en) | 1991-10-01 | 1992-10-06 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
JP5007788B2 (en) | 2005-05-16 | 2012-08-22 | 日産化学工業株式会社 | Dihydroazole-substituted benzamide compounds and pest control agents |
WO2007002696A2 (en) | 2005-06-28 | 2007-01-04 | Kaiser Daniel E | Decompressive thermogenic bandage |
JP4479917B2 (en) * | 2005-09-02 | 2010-06-09 | 日産化学工業株式会社 | Isoxazoline-substituted benzamide compounds and pest control agents |
TWI412322B (en) | 2005-12-30 | 2013-10-21 | Du Pont | Isoxazolines for controlling invertebrate pests |
PL1997813T3 (en) | 2006-03-10 | 2010-10-29 | Nissan Chemical Ind Ltd | Substituted isoxazoline compound and pest control agent |
KR20090005201A (en) | 2006-04-20 | 2009-01-12 | 이 아이 듀폰 디 네모아 앤드 캄파니 | Pyrazolines for controlling invertebrate pests |
AU2007240952A1 (en) | 2006-04-20 | 2007-11-01 | E. I. Du Pont De Nemours And Company | Five-membered heterocyclic invertebrate pest control agents |
WO2007125984A1 (en) | 2006-04-28 | 2007-11-08 | Nihon Nohyaku Co., Ltd. | Isoxazoline derivative, pest-controlling agent, and use of the pest-controlling agent |
WO2008016811A2 (en) | 2006-07-31 | 2008-02-07 | Neurogen Corporation | Aminopiperidines and realted compounds |
JP2008044880A (en) | 2006-08-15 | 2008-02-28 | Bayer Cropscience Ag | Insecticidal isooxazolines |
JP5568304B2 (en) * | 2006-09-15 | 2014-08-06 | タイロジェネクス,インコーポレイテッド | Kinase inhibitor compounds |
JP5164510B2 (en) | 2006-10-06 | 2013-03-21 | 日本曹達株式会社 | Nitrogen-containing heterocyclic compounds and pest control agents |
WO2008053942A1 (en) | 2006-10-31 | 2008-05-08 | San-Ei Gen F.F.I., Inc. | Composition for throat |
JP5164525B2 (en) | 2006-11-01 | 2013-03-21 | 日本曹達株式会社 | Nitrogen-containing heterocyclic compounds and pest control agents |
JP2008239611A (en) | 2007-02-27 | 2008-10-09 | Nissan Chem Ind Ltd | Isoxazoline-substituted benzamide compound and pesticide |
US8119671B2 (en) | 2007-03-07 | 2012-02-21 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and pest control agent |
JP5256753B2 (en) | 2007-03-29 | 2013-08-07 | 住友化学株式会社 | Isoxazoline compounds and their pest control applications |
JP5548119B2 (en) | 2007-04-10 | 2014-07-16 | バイエル・クロップサイエンス・アーゲー | Insecticidal arylisoxazoline derivatives |
WO2008130651A2 (en) | 2007-04-20 | 2008-10-30 | Dow Agrosciences Llc | Diarylisoxazolines |
JP2008266230A (en) | 2007-04-23 | 2008-11-06 | Bayer Cropscience Ag | Insecticidal arylpyrrolidines |
JP2010116389A (en) | 2008-10-17 | 2010-05-27 | Bayer Cropscience Ag | Insecticidal arylpyrrolidines |
TW200900398A (en) | 2007-05-31 | 2009-01-01 | Du Pont | 3-cyano-4-triazolyl phenylisoxazoline invertebrate pest control agents |
CA2689607A1 (en) * | 2007-06-06 | 2008-12-18 | Tyrogenex, Inc. | Kinase inhibitor compounds |
WO2008154528A2 (en) | 2007-06-13 | 2008-12-18 | E. I. Du Pont De Nemours And Company | Isoxazoline insecticides |
TWI430995B (en) | 2007-06-26 | 2014-03-21 | Du Pont | Naphthalene isoxazoline invertebrate pest control agents |
KR101714291B1 (en) | 2007-06-27 | 2017-03-08 | 이 아이 듀폰 디 네모아 앤드 캄파니 | Animal pest control method |
US8288393B2 (en) | 2007-08-10 | 2012-10-16 | Nippon Soda Co., Ltd. | Nitrogen-containing heterocyclic compound and pest control agent |
TWI556741B (en) | 2007-08-17 | 2016-11-11 | 英特威特國際股份有限公司 | Isoxazoline compositions and their use as antiparasitics |
US8318757B2 (en) | 2007-09-10 | 2012-11-27 | Nissan Chemical Industries, Ltd. | Substituted isoxazoline compound and pest control agent |
JP5676262B2 (en) | 2007-10-03 | 2015-02-25 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company | Naphthalene isoxazoline compounds for the control of harmful invertebrates |
JP2009108046A (en) | 2007-10-10 | 2009-05-21 | Nissan Chem Ind Ltd | Insecticidal, miticidal, nematicidal, molluscicidal, sterilizing, or bactericidal composition and method for controlling pest |
WO2009051956A2 (en) | 2007-10-16 | 2009-04-23 | E. I. Du Pont De Nemours And Company | Pyrazole-substituted isoxazoline insecticides |
GB0720232D0 (en) | 2007-10-16 | 2007-11-28 | Syngenta Participations Ag | Insecticidal compounds |
JPWO2009072621A1 (en) | 2007-12-07 | 2011-04-28 | 日産化学工業株式会社 | Substituted dihydroazole compounds and pest control agents |
US8410145B2 (en) | 2007-12-19 | 2013-04-02 | Syngenta Crop Protection Llc | Insecticidal compounds |
CN101939295B (en) | 2008-02-07 | 2013-04-24 | 拜尔农作物科学股份公司 | Insecticidal arylpyrrolines |
JP2009286773A (en) | 2008-03-14 | 2009-12-10 | Bayer Cropscience Ag | Insecticidal condensed-ring aryl compounds |
DE102008001932A1 (en) | 2008-05-21 | 2009-11-26 | Bayer Cropscience Ag | Substituted spiroisoxazolines |
US8563474B2 (en) | 2008-07-09 | 2013-10-22 | Basf Se | Pestcidal active mixtures comprising isoxazoline compounds I |
JP5670328B2 (en) | 2008-07-09 | 2015-02-18 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | Pesticide mixture containing isoxazoline compound II |
BRPI0917369A2 (en) | 2008-08-22 | 2015-08-04 | Syngenta Participations Ag | Insecticide Compounds |
JP2012500782A (en) | 2008-08-22 | 2012-01-12 | シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト | Insecticidal compounds |
JP2010083883A (en) | 2008-09-08 | 2010-04-15 | Nissan Chem Ind Ltd | Isoxazoline-substituted benzamide compound and harmful organism-controlling agent |
EP2332927A4 (en) | 2008-09-18 | 2012-07-18 | Nippon Soda Co | Nitrogen-containing heterocyclic compound and pest control agent |
US8377942B2 (en) | 2008-12-18 | 2013-02-19 | Novartis Ag | Isoxazolines derivatives and their use as pesticide |
CN102256971B (en) | 2008-12-19 | 2014-09-17 | 诺华股份有限公司 | Isoxazoline derivatives and their use as pesticide |
TW201029997A (en) | 2008-12-23 | 2010-08-16 | Basf Se | Imine compounds for combating invertebrate pests |
EA201100980A1 (en) | 2008-12-23 | 2012-01-30 | Басф Се | SUBSTITUTED AMIDIN COMPOUNDS FOR THE SUPPRESSION OF ANIMAL WARMERS |
CN102292331A (en) | 2009-01-22 | 2011-12-21 | 先正达参股股份有限公司 | Insecticidal compounds |
JP2010235590A (en) | 2009-03-09 | 2010-10-21 | Nissan Chem Ind Ltd | Substituted isoxazoline compound and pesticide |
EP2411384B1 (en) | 2009-03-26 | 2013-01-30 | Syngenta Participations AG | Insecticidal compounds |
JP2012522750A (en) | 2009-04-01 | 2012-09-27 | ビーエーエスエフ ソシエタス・ヨーロピア | Isoxazoline compounds for combating invertebrate pests |
JP2010254629A (en) | 2009-04-27 | 2010-11-11 | Bayer Cropscience Ag | Optically active azoline derivative |
CN102414175A (en) | 2009-04-30 | 2012-04-11 | 拜耳作物科学公司 | Pesticidal arylpyrrolidines |
BRPI1010909A2 (en) | 2009-05-19 | 2015-09-08 | Bayer Cropscience Ag | "arylpyrroline insecticide" |
MA33372B1 (en) | 2009-06-22 | 2012-06-01 | Syngenta Participations Ag | Pesticide compounds |
JP2011037817A (en) | 2009-07-16 | 2011-02-24 | Nissan Chem Ind Ltd | Insecticidal, miticidal, nematicidal, molluscicidal, fungicidal, or bactericidal agent composition and pest controlling method |
EP4101394A1 (en) | 2009-09-25 | 2022-12-14 | Boston Scientific Scimed, Inc. | Devices for approximating tissue |
JP2011093855A (en) | 2009-10-30 | 2011-05-12 | Bayer Cropscience Ag | Insecticidal oxazolidinone derivative |
CN102725286A (en) | 2009-11-06 | 2012-10-10 | 拜耳作物科学公司 | Insecticidal arylpyrroline compounds |
RU2549900C9 (en) | 2009-12-17 | 2016-09-20 | Мериал Лимитед | Antiparasitic dihydroazol compounds and compositions containing them |
WO2011073444A2 (en) | 2009-12-18 | 2011-06-23 | Basf Se | Azoline compounds for combating invertebrate pests |
JP2013518084A (en) | 2010-02-01 | 2013-05-20 | ビーエーエスエフ ソシエタス・ヨーロピア | Substituted ketonic isoxazoline compounds and derivatives for controlling pests |
US8754053B2 (en) | 2010-02-17 | 2014-06-17 | Syngenta Crop Protection Llc | Isoxazoline derivatives as insecticides |
AU2011217466B2 (en) | 2010-02-22 | 2015-02-26 | Syngenta Participations Ag | Dihydrofuran derivatives as insecticidal compounds |
EP2539335B1 (en) | 2010-02-25 | 2016-12-21 | Syngenta Participations AG | Process for the preparation of isoxazoline derivatives |
CA2791067A1 (en) | 2010-02-25 | 2011-09-01 | Syngenta Participations Ag | Pesticidal mixtures containing isoxazoline derivatives and insecticide or nematoicidal biological agent |
BR112012021238A2 (en) | 2010-02-25 | 2016-06-21 | Syngenta Ltd | pesticide mixtures containing isoxazoline derivatives and a fungicide |
JP2011178673A (en) | 2010-02-26 | 2011-09-15 | Nissan Chem Ind Ltd | Control method for non-agricultural/horticultural insect pest |
AU2011236510A1 (en) | 2010-04-08 | 2012-10-11 | Zoetis Llc | Substituted 3,5- di phenyl - isoxazoline derivatives as insecticides and acaricides |
JP2011219431A (en) | 2010-04-13 | 2011-11-04 | Bayer Cropscience Ag | New aryl nitroalkane derivative |
PL2576523T3 (en) | 2010-05-27 | 2016-08-31 | Du Pont | Crystalline form of 4-[5 - [3 -chloro-5 -(trifluoromethyl)phenyl] -4,5 -dihydro-5 -(trifluoromethyl)-3 - isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1- naphthalenecarboxamide |
EP2579725A2 (en) | 2010-06-09 | 2013-04-17 | Syngenta Participations AG | Pesticidal mixtures including isoxazoline derivatives |
EP2579723A2 (en) | 2010-06-09 | 2013-04-17 | Syngenta Participations AG | Pesticidal mixtures comprising isoxazoline derivatives |
US20130210623A1 (en) | 2010-06-09 | 2013-08-15 | Syngenta Crop Protection Llc | Pesticidal mixtures including isoxazoline derivatives |
UY33403A (en) | 2010-06-17 | 2011-12-30 | Novartis Ag | ORGANIC COMPOUNDS WITH NEW ISOXAZOLINES, THEIR N-OXIDES, S-OXIDES AND SALTS |
DK178277B1 (en) | 2010-06-18 | 2015-10-26 | Novartis Tiergesundheit Ag | Diaryloxazoline compounds for the control of fish lice |
JP2012031148A (en) | 2010-06-28 | 2012-02-16 | Nissan Chem Ind Ltd | Animal parasitic preventive exterminator |
JP2012017289A (en) | 2010-07-08 | 2012-01-26 | Bayer Cropscience Ag | Pesticidal pyrroline derivative |
WO2012007426A1 (en) | 2010-07-13 | 2012-01-19 | Basf Se | Azoline substituted isoxazoline benzamide compounds for combating animal pests |
JP2012046486A (en) | 2010-07-30 | 2012-03-08 | Sumitomo Chemical Co Ltd | Animal ectoparasite-controlling agent |
JP2012046488A (en) | 2010-07-30 | 2012-03-08 | Sumitomo Chemical Co Ltd | Animal ectoparasite-controlling agent |
JP2012046485A (en) | 2010-07-30 | 2012-03-08 | Sumitomo Chemical Co Ltd | Animal ectoparasite-controlling agent |
JP2012046487A (en) | 2010-07-30 | 2012-03-08 | Sumitomo Chemical Co Ltd | Animal ectoparasite-controlling agent |
JP2012031095A (en) | 2010-07-30 | 2012-02-16 | Sumitomo Chemical Co Ltd | Animal ectoparasiticide |
JP2012031093A (en) | 2010-07-30 | 2012-02-16 | Sumitomo Chemical Co Ltd | Animal ectoparasite controller |
JP2012031094A (en) | 2010-07-30 | 2012-02-16 | Sumitomo Chemical Co Ltd | Animal ectoparasiticide |
BR112013002871B1 (en) | 2010-08-05 | 2018-11-21 | Zoetis Llc | isoxazoline derivatives, their use and pharmaceutical or veterinary composition |
JP5653442B2 (en) | 2010-08-23 | 2015-01-14 | 日本曹達株式会社 | Fused ring compounds |
JP2012051843A (en) | 2010-09-02 | 2012-03-15 | Nissan Chem Ind Ltd | Composition for insecticide, mitecide, nematocide, molluscicide, germicide, or bactreiacide, and method of controlling pest |
JP2012082186A (en) | 2010-09-15 | 2012-04-26 | Bayer Cropscience Ag | Insecticidal arylpyrrolidines |
JP2012062267A (en) | 2010-09-15 | 2012-03-29 | Bayer Cropscience Ag | Pesticidal pyrroline n-oxide derivative |
WO2012038851A1 (en) | 2010-09-24 | 2012-03-29 | Pfizer Inc. | Isoxazoline oximes as antiparasitic agents |
CN103153949A (en) | 2010-10-05 | 2013-06-12 | 先正达参股股份有限公司 | Insecticidal pyrrolidin-yl-aryl-carboxamides |
WO2012049327A2 (en) | 2010-10-15 | 2012-04-19 | Syngenta Participations Ag | Pesticidal mixtures |
JP2014015397A (en) | 2010-11-04 | 2014-01-30 | Nippon Soda Co Ltd | External parasite controlling agent for animals |
JP2014028758A (en) | 2010-11-19 | 2014-02-13 | Nissan Chem Ind Ltd | Agent for controlling parasite and sanitary insect pest |
-
2010
- 2010-11-29 TW TW099141199A patent/TWI487486B/en active
- 2010-11-30 AR ARP100104408A patent/AR079224A1/en active IP Right Grant
- 2010-11-30 SA SA110310884A patent/SA110310884B1/en unknown
- 2010-12-01 UY UY0001033070A patent/UY33070A/en active IP Right Grant
- 2010-12-01 LT LTEP10787393.7T patent/LT2507230T/en unknown
- 2010-12-01 PT PT107873937T patent/PT2507230T/en unknown
- 2010-12-01 MX MX2012006171A patent/MX2012006171A/en active IP Right Grant
- 2010-12-01 NZ NZ600036A patent/NZ600036A/en unknown
- 2010-12-01 JP JP2012541480A patent/JP5980119B2/en active Active
- 2010-12-01 HU HUE10787393A patent/HUE036528T2/en unknown
- 2010-12-01 DK DK10787393.7T patent/DK2507230T3/en active
- 2010-12-01 AU AU2010326766A patent/AU2010326766C1/en active Active
- 2010-12-01 EA EA201200826A patent/EA022114B1/en not_active IP Right Cessation
- 2010-12-01 PL PL10787393T patent/PL2507230T3/en unknown
- 2010-12-01 GE GEAP201012770A patent/GEP20146161B/en unknown
- 2010-12-01 MY MYPI2012002218A patent/MY157849A/en unknown
- 2010-12-01 BR BR112012013085-4A patent/BR112012013085B1/en active IP Right Grant
- 2010-12-01 EP EP10787393.7A patent/EP2507230B1/en active Active
- 2010-12-01 AP AP2012006285A patent/AP2012006285A0/en unknown
- 2010-12-01 KR KR1020127014101A patent/KR101771199B1/en active Protection Beyond IP Right Term
- 2010-12-01 ES ES10787393.7T patent/ES2666415T3/en active Active
- 2010-12-01 CN CN201080054495.6A patent/CN102639529B/en active Active
- 2010-12-01 WO PCT/EP2010/068605 patent/WO2011067272A1/en active Application Filing
- 2010-12-01 CA CA2780522A patent/CA2780522C/en active Active
- 2010-12-01 US US13/512,820 patent/US8735362B2/en active Active
-
2012
- 2012-05-16 ZA ZA2012/03587A patent/ZA201203587B/en unknown
- 2012-05-21 IL IL219912A patent/IL219912A/en active IP Right Grant
- 2012-05-30 TN TNP2012000276A patent/TN2012000276A1/en unknown
- 2012-05-31 CO CO12091196A patent/CO6541622A2/en active IP Right Grant
- 2012-05-31 CL CL2012001430A patent/CL2012001430A1/en unknown
- 2012-05-31 NI NI201200098A patent/NI201200098A/en unknown
- 2012-05-31 MA MA34920A patent/MA33782B1/en unknown
- 2012-05-31 CR CR20120299A patent/CR20120299A/en unknown
- 2012-05-31 EC ECSP12011940 patent/ECSP12011940A/en unknown
-
2014
- 2014-04-22 US US14/258,079 patent/US9609869B2/en active Active
-
2017
- 2017-02-10 US US15/429,631 patent/US10206400B2/en active Active
-
2018
- 2018-12-28 AR ARP180103900A patent/AR114064A2/en active IP Right Grant
-
2019
- 2019-02-05 US US16/267,562 patent/US10750745B2/en active Active
-
2020
- 2020-08-24 US US17/000,978 patent/US11357231B2/en active Active
Patent Citations (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4639771A (en) | 1984-10-31 | 1987-01-27 | Kabushiki Kaisha Toshiba | Image processing system |
EP0357460A2 (en) | 1988-09-02 | 1990-03-07 | Sankyo Company Limited | 13-Substituted milbemycin derivatives, their preparation and use |
US5015630A (en) | 1989-01-19 | 1991-05-14 | Merck & Co., Inc. | 5-oxime avermectin derivatives |
EP0382173A2 (en) | 1989-02-07 | 1990-08-16 | Meiji Seika Kaisha Ltd. | PF 1022 substance, method of producing same and anthelmintic composition containing same |
EP0444964A1 (en) | 1990-03-01 | 1991-09-04 | Sankyo Company Limited | Milbemycin ether derivatives, their preparation and their anthelmintic uses |
EP0503538A1 (en) | 1991-03-08 | 1992-09-16 | Meiji Seika Kaisha Ltd. | Medicinal composition containing an anthelmintic cyclic depsipeptide |
WO1993019053A1 (en) | 1992-03-17 | 1993-09-30 | Fujisawa Pharmaceutical Co., Ltd. | Depsipeptide derivative, production thereof and use thereof |
US5478855A (en) | 1992-04-28 | 1995-12-26 | Yashima Chemical Industry Co., Ltd. | 2-(2,6-difluorophenyl)-4-(2-ethoxy-4-tert-butylphenyl)-2-oxazoline |
WO1993025543A2 (en) | 1992-06-11 | 1993-12-23 | Bayer Aktiengesellschaft | Enniatines and enniatine derivates used to control endoparasites |
EP0594291A1 (en) | 1992-09-01 | 1994-04-27 | Sankyo Company Limited | Novel processes for the production of 13-ether derivatives of milbemycins, and novel intermediates therefor |
WO1994015944A1 (en) | 1993-01-18 | 1994-07-21 | Pfizer Limited | New antiparasitic agents related to the milbemycins and avermectins |
WO1994019334A1 (en) | 1993-02-19 | 1994-09-01 | Meiji Seika Kaisha, Ltd. | Pf1022 derivative, cyclic depsipeptide |
EP0626375A1 (en) | 1993-05-26 | 1994-11-30 | Bayer Ag | Octacyclodepsipeptides having endoparasiticidal activity |
WO1995019363A1 (en) | 1994-01-14 | 1995-07-20 | Pfizer Inc. | Antiparasitic pyrrolobenzoxazine compounds |
WO1995022552A1 (en) | 1994-02-16 | 1995-08-24 | Pfizer Limited | Antiparasitic agents |
WO1996011945A2 (en) | 1994-10-18 | 1996-04-25 | Bayer Aktiengesellschaft | Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process |
WO1996015121A1 (en) | 1994-11-10 | 1996-05-23 | Bayer Aktiengesellschaft | Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production |
DE19520936A1 (en) | 1995-06-08 | 1996-12-12 | Bayer Ag | Ectoparasiticides means |
WO2003024222A1 (en) | 2001-09-21 | 2003-03-27 | E. I. Du Pont De Nemours And Company | Anthranilamide arthropodicide treatment |
WO2004072086A2 (en) | 2003-02-14 | 2004-08-26 | Pfizer Limited | Antiparasitic terpene alkaloids |
US20070066617A1 (en) | 2004-03-05 | 2007-03-22 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and pesticide |
WO2005085216A1 (en) | 2004-03-05 | 2005-09-15 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and noxious organism control agent |
EP1731512A1 (en) | 2004-03-05 | 2006-12-13 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and noxious organism control agent |
JP2007008914A (en) | 2004-10-27 | 2007-01-18 | Nissan Chem Ind Ltd | Substituted diamine compound and agricultural and horticultural bactericide |
JP2007016017A (en) | 2005-06-06 | 2007-01-25 | Nissan Chem Ind Ltd | Substituted isoxazoline compound and pest control agent |
EP1932836A1 (en) * | 2005-09-02 | 2008-06-18 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and harmful organism-controlling agent |
WO2007026965A1 (en) | 2005-09-02 | 2007-03-08 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and harmful organism-controlling agent |
JP2007106756A (en) | 2005-09-14 | 2007-04-26 | Nissan Chem Ind Ltd | Substituted isoxazoline compound and pesticide |
WO2007070606A2 (en) | 2005-12-14 | 2007-06-21 | E. I. Du Pont De Nemours And Company | Isoxazolines for controlling invertebrate pests |
WO2007075459A2 (en) | 2005-12-16 | 2007-07-05 | E. I. Du Pont De Nemours And Company | 5-aryl isoxazolines for controlling invertebrate pests |
WO2007074789A1 (en) | 2005-12-26 | 2007-07-05 | Nissan Chemical Industries, Ltd. | 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof |
DE102006015467A1 (en) | 2006-03-31 | 2007-10-04 | Bayer Cropscience Ag | New cyclic enamine ketone derivatives useful for controlling pests, especially insects |
WO2009001942A1 (en) | 2007-06-27 | 2008-12-31 | Nissan Chemical Industries, Ltd. | Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound, and method for production of isoxazoline compound |
WO2009080250A2 (en) | 2007-12-24 | 2009-07-02 | Syngenta Participations Ag | Insecticidal compounds |
WO2010025998A1 (en) | 2008-09-04 | 2010-03-11 | Syngenta Participations Ag | Insecticidal compounds |
WO2010086225A1 (en) * | 2009-01-29 | 2010-08-05 | Syngenta Participations Ag | Insecticidal compounds |
Non-Patent Citations (15)
Title |
---|
"Angewandte Chemie", vol. 45, 2006, pages: 154 - 158 |
CHEM. PHARM. BULL., vol. 50, no. 4, 2002, pages 554 - 557 |
D. S. KETTLE: "Medical and Veterinary Entomology", JOHN WILEY AND SONS |
E. J. L. SOULSBY: "Helminths, Arthropods and Protozoa", WILLIAMS AND WILKINS CO., article "Monnig's Veterinary Helminthology and Entomology" |
HELMINTHS, E. J. L.; SOULSBY, F. A.: "Textbook of Veterinary Clinical Parasitology", vol. 1, DAVIS CO. |
J AM. CHEM. SOC., vol. 118, 1996, pages 7094 - 7100 |
J MED. CHEM., vol. 41, 1998, pages 236 - 246 |
J. ORG. CHEM., vol. 46, 1981, pages 5408 - 5413 |
MCCUTCHEON'S: "Functional Materials", vol. 2, MCCUTCHEON'S DIVISION, THE MANUFACTURING CONFECTIONER PUBLISHING CO. |
ORG. BIOMOL. CHEM., vol. 6, 2008, pages 1902 - 1904 |
R. O. DRUMMAND; J. E. GEORGE; S. E. KUNZ: "Control of Arthropod Pests of Livestock: A Review of Technology", CRC PRESS |
SYNTHESIS, vol. 8, 1998, pages 1113 - 1118 |
TETRAHEDRON, vol. 44, no. 1, 1998, pages 3231 - 3240 |
TETRAHEDRON, vol. 46, 1990, pages 1975 - 1986 |
TETRAHEDRON, vol. 55, 1999, pages 4685 - 4698 |
Cited By (216)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011104089A1 (en) * | 2010-02-25 | 2011-09-01 | Syngenta Participations Ag | Process for the preparation of isoxazoline derivatives |
US9637480B2 (en) | 2010-11-19 | 2017-05-02 | Nissan Chemical Industries, Ltd. | Parasite- and hygienic pest-controlling agent |
WO2012067235A1 (en) * | 2010-11-19 | 2012-05-24 | 日産化学工業株式会社 | Control agent against parasite and sanitary insect |
US9029409B2 (en) | 2011-04-30 | 2015-05-12 | Abbvie Inc. | Isoxazolines as therapeutic agents |
AU2012250979B2 (en) * | 2011-04-30 | 2015-07-30 | Abbvie Inc. | Isoxazolines as therapeutic agents |
US9339505B2 (en) | 2011-05-31 | 2016-05-17 | Syngenta Participations Ag | Pesticidal mixtures including isoxazoline derivatives |
CN103717068A (en) * | 2011-05-31 | 2014-04-09 | 先正达参股股份有限公司 | Pesticidal mixtures comprising isoxazoline derivatives |
CN103562189A (en) * | 2011-05-31 | 2014-02-05 | 先正达参股股份有限公司 | Insecticidal compounds |
TWI555471B (en) * | 2011-05-31 | 2016-11-01 | 先正達合夥公司 | Pesticidal mixtures including isoxazoline derivatives |
US9439431B2 (en) | 2011-05-31 | 2016-09-13 | Syngenta Participations Ag | Pesticidal mixtures comprising isoxazoline derivatives |
US9402399B2 (en) | 2011-05-31 | 2016-08-02 | Syngenta Participations Ag | Pesticidal mixtures including isoxazoline derivatives |
KR101959930B1 (en) | 2011-05-31 | 2019-03-19 | 신젠타 파티서페이션즈 아게 | Pesticidal mixtures comprising isoxazoline derivatives |
KR20140037881A (en) * | 2011-05-31 | 2014-03-27 | 신젠타 파티서페이션즈 아게 | Pesticidal mixtures comprising isoxazoline derivatives |
KR20140041534A (en) * | 2011-05-31 | 2014-04-04 | 신젠타 파티서페이션즈 아게 | Pesticidal mixtures including isoxazoline derivatives |
US10869477B2 (en) | 2011-05-31 | 2020-12-22 | Syngenta Participations Ag | Insecticidal compounds |
WO2012163960A1 (en) * | 2011-05-31 | 2012-12-06 | Syngenta Participations Ag | Pesticidal mixtures including isoxazoline derivatives |
US9913471B2 (en) | 2011-05-31 | 2018-03-13 | Syngenta Participations Ag | Insecticidal compounds |
US9545106B2 (en) | 2011-05-31 | 2017-01-17 | Syngenta Participations Ag | Insecticidal compounds |
KR101959837B1 (en) | 2011-05-31 | 2019-03-19 | 신젠타 파티서페이션즈 아게 | Pesticidal mixtures including isoxazoline derivatives |
WO2012163948A1 (en) * | 2011-05-31 | 2012-12-06 | Syngenta Participations Ag | Pesticidal mixtures including isoxazoline derivatives |
WO2012163945A1 (en) * | 2011-05-31 | 2012-12-06 | Syngenta Participations Ag | Pesticidal mixtures comprising isoxazoline derivatives |
CN103717068B (en) * | 2011-05-31 | 2016-02-03 | 先正达参股股份有限公司 | Pest mixture is killed containing isoxazoline derivative |
WO2013026930A1 (en) | 2011-08-25 | 2013-02-28 | Syngenta Participations Ag | Process for the preparation of thietane derivatives |
US10786487B2 (en) | 2011-09-12 | 2020-09-29 | Boehringer Ingelheim Animal Health USA Inc. | Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof |
US9877950B2 (en) | 2011-09-12 | 2018-01-30 | Merial Inc. | Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof |
US10383854B2 (en) | 2011-09-12 | 2019-08-20 | Boehringer Ingelheim Animal Health USA Inc. | Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof |
US9180121B2 (en) | 2011-09-12 | 2015-11-10 | Merial, Inc. | Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof |
US11464763B2 (en) | 2011-09-12 | 2022-10-11 | Boehringer Ingelheim Animal Health USA Inc. | Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof |
CN103842346A (en) * | 2011-10-03 | 2014-06-04 | 先正达参股股份有限公司 | Isoxazoline derivatives as insecticidal compounds |
WO2013050302A1 (en) | 2011-10-03 | 2013-04-11 | Syngenta Participations Ag | Isoxazoline derivatives as insecticidal compounds |
JPWO2013069731A1 (en) * | 2011-11-08 | 2015-04-02 | 日産化学工業株式会社 | Catalytic asymmetric synthesis method of optically active isoxazoline compound and optically active isoxazoline compound |
US9126995B2 (en) | 2011-11-08 | 2015-09-08 | Nissan Chemical Industries, Ltd. | Method for catalytic asymmetric synthesis of optically active isoxazoline compound and optically active isoxazoline compound |
JP2015502967A (en) * | 2011-12-23 | 2015-01-29 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | Isothiazoline compounds for combating invertebrate pests |
US9732051B2 (en) | 2011-12-23 | 2017-08-15 | Basf Se | Isothiazoline compounds for combating invertebrate pests |
US9233100B2 (en) | 2012-02-06 | 2016-01-12 | Merial, Inc. | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof |
US9259417B2 (en) | 2012-02-06 | 2016-02-16 | Merial, Inc. | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof |
US9931320B2 (en) | 2012-02-06 | 2018-04-03 | Merial Inc. | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof |
US10596156B2 (en) | 2012-02-06 | 2020-03-24 | Boehringer Ingelheim Animal Health USA Inc. | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof |
US10375961B2 (en) | 2012-02-27 | 2019-08-13 | Bayer Intellectual Property Gmbh | Active compound combinations containing a thiazoylisoxazoline and a fungicide |
US11147274B2 (en) | 2012-02-27 | 2021-10-19 | Bayer Intellectual Property Gmbh | Active compound combinations containing a thiazoylisoxazoline and a fungicide |
US11285101B2 (en) | 2012-04-04 | 2022-03-29 | Intervet Inc. | Soft chewable pharmaceutical products |
US11337917B2 (en) | 2012-04-04 | 2022-05-24 | Intervet Inc. | Soft chewable pharmaceutical products |
JP2015514103A (en) * | 2012-04-04 | 2015-05-18 | インターベット インターナショナル ベー. フェー. | Soft chewable pharmaceutical products |
CN104519739A (en) * | 2012-08-03 | 2015-04-15 | 先正达参股股份有限公司 | Methods of pest control in soybean |
US20150164078A1 (en) * | 2012-08-03 | 2015-06-18 | Syngenta Participations Ag | Methods of pest control in soybean |
WO2014019950A1 (en) | 2012-08-03 | 2014-02-06 | Syngenta Participations Ag | Methods of pest control in soybean |
US11930816B2 (en) | 2012-08-03 | 2024-03-19 | Syngenta Participations Ag | Methods of pest control in soybean |
WO2014029709A1 (en) | 2012-08-24 | 2014-02-27 | Syngenta Participations Ag | Methods of controlling insects |
US9474279B2 (en) | 2012-08-24 | 2016-10-25 | Syngenta Participations Ag | Methods of controlling insects |
US9661850B2 (en) | 2012-08-24 | 2017-05-30 | Syngenta Participations Ag | Methods of soil pest control |
KR102105863B1 (en) * | 2012-08-24 | 2020-05-04 | 신젠타 파티서페이션즈 아게 | Methods of controlling insects |
AU2013305089B2 (en) * | 2012-08-24 | 2016-11-10 | Syngenta Participations Ag | Methods of controlling insects |
RU2636978C2 (en) * | 2012-08-24 | 2017-11-29 | Зингента Партисипейшнс Аг | Methods of controlling soil pests |
AU2013305200B2 (en) * | 2012-08-24 | 2016-10-20 | Syngenta Participations Ag | Methods of soil pest control |
WO2014029639A1 (en) | 2012-08-24 | 2014-02-27 | Syngenta Participations Ag | Methods of soil pest control |
WO2014029640A1 (en) | 2012-08-24 | 2014-02-27 | Syngenta Participations Ag | Methods of controlling insects |
JP2015529662A (en) * | 2012-08-24 | 2015-10-08 | シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト | How to control insects |
KR20150047495A (en) * | 2012-08-24 | 2015-05-04 | 신젠타 파티서페이션즈 아게 | Methods of controlling insects |
US9320278B2 (en) | 2012-08-24 | 2016-04-26 | Syngenta Participations Ag | Methods of controlling insects |
US10786494B2 (en) | 2013-12-02 | 2020-09-29 | Chemocentryx, Inc. | CCR6 compounds |
US9340509B2 (en) | 2013-12-02 | 2016-05-17 | Chemocentryx, Inc. | CCR6 compounds |
US10117865B2 (en) | 2013-12-02 | 2018-11-06 | Chemocentryx, Inc. | CCR6 compounds |
US9795599B2 (en) | 2013-12-02 | 2017-10-24 | Chemocentryx, Inc. | CCR6 compounds |
US9968087B2 (en) | 2014-02-26 | 2018-05-15 | Basf Se | Azoline compounds |
US10226045B2 (en) | 2014-02-26 | 2019-03-12 | Basf Se | Azoline compounds |
EP3178322A4 (en) * | 2014-07-28 | 2018-02-28 | Sumitomo Chemical Company Limited | Amide compound and use of same for noxious arthropod control |
JPWO2016017467A1 (en) * | 2014-07-28 | 2017-04-27 | 住友化学株式会社 | Amide compounds and their use for controlling harmful arthropods |
US10251396B2 (en) | 2014-07-28 | 2019-04-09 | Sumitomo Chemical Company, Limited | Amide compound and use of same for noxious arthropod control |
TWI664905B (en) * | 2014-07-29 | 2019-07-11 | 日商住友化學股份有限公司 | Noxious arthropod controlling agent containing amide compound |
EP3178323A4 (en) * | 2014-07-29 | 2018-02-07 | Sumitomo Chemical Company, Limited | Noxious arthropod control agent containing amide compound |
TWI699362B (en) * | 2014-08-11 | 2020-07-21 | 瑞士商先正達合夥公司 | Process for the preparation of optically active isoxazoline compounds |
WO2016023787A1 (en) * | 2014-08-11 | 2016-02-18 | Syngenta Participations Ag | Process for the preparation of optically active isoxazoline compounds |
KR102497654B1 (en) | 2014-08-11 | 2023-02-08 | 신젠타 파티서페이션즈 아게 | Process for the preparation of optically active isoxazoline compounds |
US9815829B2 (en) | 2014-08-11 | 2017-11-14 | Syngenta Participations Ag | Process for the preparation of optically active isoxazoline compounds |
KR20170035937A (en) * | 2014-08-11 | 2017-03-31 | 신젠타 파티서페이션즈 아게 | Process for the preparation of optically active isoxazoline compounds |
US10093662B2 (en) | 2014-12-22 | 2018-10-09 | Basf Se | Azoline compounds substituted by a condensed ring system |
US10273231B2 (en) | 2014-12-22 | 2019-04-30 | Basf Se | Azoline compounds substituted by a condensed ring system |
US10085448B2 (en) | 2014-12-22 | 2018-10-02 | Basf Se | Azoline compounds substituted by a carbocyclic condensed ring system |
US10588317B2 (en) | 2015-09-23 | 2020-03-17 | Syngenta Participations Ag | Isoxazoline-substituted benzamides and analogues as insecticides |
WO2017050921A1 (en) * | 2015-09-23 | 2017-03-30 | Syngenta Participations Ag | Isoxazoline-substituted benzamides and analogues as insecticides |
US10499642B2 (en) | 2015-09-23 | 2019-12-10 | Syngenta Participations Ag | Isoxazoline-substituted benzamides and analogues as insecticides |
WO2017050922A1 (en) | 2015-09-23 | 2017-03-30 | Syngenta Participations Ag | Isoxazoline-substituted benzamides and analogues as insecticides |
WO2017102006A1 (en) | 2015-12-17 | 2017-06-22 | Syngenta Participations Ag | Microbiocidal oxadiazole derivatives |
WO2017140614A1 (en) | 2016-02-19 | 2017-08-24 | Basf Se | Method for controlling pests of soybean, corn, and cotton plants |
US11324220B2 (en) | 2016-04-06 | 2022-05-10 | Boehringer Ingelheim Animal Health USA Inc. | Process for the preparation of isoxazoline compounds |
US10433552B2 (en) | 2016-04-06 | 2019-10-08 | Merial, Inc. | Process for the preparation of isoxazoline compounds |
US10750744B2 (en) | 2016-04-06 | 2020-08-25 | Boehringer Ingelheim Animal Health USA Inc. | Process for the preparation of isoxazoline compounds |
WO2018039508A1 (en) * | 2016-08-25 | 2018-03-01 | Merial, Inc. | Method for reducing unwanted effects in parasiticidal treatments |
US10959431B2 (en) * | 2016-10-10 | 2021-03-30 | Basf Se | Pesticidal mixtures |
US20200045971A1 (en) * | 2016-10-10 | 2020-02-13 | Basf Se | Pesticidal mixtures |
WO2018114791A1 (en) | 2016-12-19 | 2018-06-28 | Syngenta Participations Ag | Pesticidally active azetidine sulfones amide isoxazoline derivatives |
EP3336086A1 (en) | 2016-12-19 | 2018-06-20 | Syngenta Participations Ag | Pesticidally active azetidine sulfone amide isoxazoline derivatives |
EP3336087A1 (en) | 2016-12-19 | 2018-06-20 | Syngenta Participations Ag | Pesticidally active azetidine sulfone amide isoxazoline derivatives |
WO2018114790A1 (en) | 2016-12-19 | 2018-06-28 | Syngenta Participations Ag | Pesticidally active azetidine sulfones amide isoxazoline derivatives |
WO2018139560A1 (en) | 2017-01-26 | 2018-08-02 | 三井化学アグロ株式会社 | Pyridone compound and bactericide for agricultural and horticultural use, which uses said compound as active ingredient |
WO2018172471A1 (en) | 2017-03-22 | 2018-09-27 | Syngenta Participations Ag | Pesticidally active cyclopropyl methyl amide derivatives |
WO2018172480A1 (en) | 2017-03-23 | 2018-09-27 | Syngenta Participations Ag | Insecticidal compounds |
US11104671B2 (en) | 2017-03-23 | 2021-08-31 | Syngenta Participations Ag | Insecticidal compounds |
WO2018172477A1 (en) | 2017-03-23 | 2018-09-27 | Syngenta Participations Ag | Insecticidal compounds |
US11213032B2 (en) | 2017-03-23 | 2022-01-04 | Syngenta Participations Ag | Insecticidal compounds |
WO2018190350A1 (en) | 2017-04-10 | 2018-10-18 | 三井化学アグロ株式会社 | Pyridone compound, and agricultural and horticultural fungicide having this as active component |
WO2018190351A1 (en) | 2017-04-10 | 2018-10-18 | 三井化学アグロ株式会社 | Pyridone compound, and agricultural and horticultural fungicide having this as active component |
WO2018190352A1 (en) | 2017-04-11 | 2018-10-18 | 三井化学アグロ株式会社 | Pyridone compound, and agricultural and horticultural fungicide having this as active component |
WO2018225829A1 (en) | 2017-06-08 | 2018-12-13 | 三井化学アグロ株式会社 | Pyridone compound and agricultural and horticultural fungicide |
WO2018234478A1 (en) * | 2017-06-23 | 2018-12-27 | Basf Se | Pesticidal mixtures comprising a pyrazole compound |
AU2018287131B2 (en) * | 2017-06-23 | 2023-10-12 | Basf Se | Pesticidal mixtures comprising a pyrazole compound |
WO2019105871A1 (en) | 2017-11-29 | 2019-06-06 | Bayer Aktiengesellschaft | Nitrogenous heterocycles as a pesticide |
US11104672B2 (en) | 2017-12-19 | 2021-08-31 | Syngenta Participations Ag | Polymorphs |
WO2019121394A1 (en) | 2017-12-19 | 2019-06-27 | Syngenta Participations Ag | Polymorphs |
WO2019170626A1 (en) | 2018-03-08 | 2019-09-12 | Bayer Aktiengesellschaft | Use of heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides in plant protection |
EP3904349A2 (en) | 2018-04-12 | 2021-11-03 | Bayer Aktiengesellschaft | N-(cyclopropylmethyl)-5-(methylsulfonyl)-n-{1-[1-(pyrimidin-2-yl)-1h-1,2,4-triazol-5-yl]ethyl}heterocyclyl amide derivatives and similar compounds as pesticides |
EP3904350A1 (en) | 2018-04-12 | 2021-11-03 | Bayer Aktiengesellschaft | N-(cyclopropylmethyl)-5-(methylsulfonyl)-n-{1-[1-(pyrimidin-2-yl)-1h-1,2,4-triazol-5-yl]ethyl}benzamide derivatives and the corresponding pyridine-carboxamide derivatives as pesticides |
WO2019197468A1 (en) | 2018-04-12 | 2019-10-17 | Bayer Aktiengesellschaft | N-(cyclopropylmethyl)-5-(methylsulfonyl)-n-{1-[1-(pyrimidin-2-yl)-1h-1,2,4-triazol-5-yl]ethyl}benzamide derivatives and the corresponding pyridine-carboxamide derivatives as pesticides |
EP3919486A1 (en) | 2018-04-25 | 2021-12-08 | Bayer Aktiengesellschaft | Novel heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides |
WO2019206799A1 (en) | 2018-04-25 | 2019-10-31 | Bayer Aktiengesellschaft | Novel heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides |
WO2019243253A1 (en) | 2018-06-19 | 2019-12-26 | Syngenta Crop Protection Ag | Pesticidally active isoxazoline derivatives containing an amide group and an azetidine sulfone group |
WO2019243262A1 (en) | 2018-06-19 | 2019-12-26 | Syngenta Crop Protection Ag | Pesticidally active azetidine sulfones amide isoxazoline derivatives |
WO2019243256A1 (en) | 2018-06-19 | 2019-12-26 | Syngenta Crop Protection Ag | Pesticidally active isoxazoline derivatives containing an amide group and an azetidine sulfone group |
WO2019243263A1 (en) | 2018-06-19 | 2019-12-26 | Syngenta Participations Ag | Insecticidal compounds |
EP3586630A1 (en) | 2018-06-28 | 2020-01-01 | Bayer AG | Active compound combinations having insecticidal/acaricidal properties |
WO2020022412A1 (en) | 2018-07-25 | 2020-01-30 | 三井化学アグロ株式会社 | Pyridone compound and agricultural and horticultural fungicide having this as active component |
WO2020043650A1 (en) | 2018-08-29 | 2020-03-05 | Bayer Aktiengesellschaft | Active compound combinations having insecticidal/acaricidal properties |
WO2020064569A1 (en) | 2018-09-26 | 2020-04-02 | Syngenta Crop Protection Ag | Insecticidal compounds |
WO2020064565A1 (en) | 2018-09-26 | 2020-04-02 | Syngenta Crop Protection Ag | Insecticidal compounds |
WO2020064560A1 (en) | 2018-09-26 | 2020-04-02 | Syngenta Crop Protection Ag | Pesticidally active cyclopropyl methyl amide derivatives |
WO2020064564A1 (en) | 2018-09-26 | 2020-04-02 | Syngenta Participations Ag | Insecticidal compounds |
EP3636644A1 (en) | 2018-10-11 | 2020-04-15 | Bayer Aktiengesellschaft | Mesoionic imidazopyridines as insecticides |
WO2020078839A1 (en) | 2018-10-16 | 2020-04-23 | Bayer Aktiengesellschaft | Active substance combinations |
WO2020088949A1 (en) | 2018-10-29 | 2020-05-07 | Basf Se | Process for preparation of optically enriched aldol compounds |
WO2020094434A1 (en) | 2018-11-06 | 2020-05-14 | Basf Se | Process for preparation of optically enriched isoxazolines |
US11440861B2 (en) | 2018-12-04 | 2022-09-13 | Basf Se | Process for preparation of 5-bromo-1,3-dichloro-2-fluoro-benzene |
CN113166004A (en) * | 2018-12-04 | 2021-07-23 | 巴斯夫欧洲公司 | Method for preparing 5-bromo-1, 3-dichloro-2-fluorobenzene |
WO2020114813A1 (en) | 2018-12-04 | 2020-06-11 | Basf Se | Process for preparation of 5-bromo-1,3-dichloro-2-fluoro-benzene |
WO2020114932A1 (en) | 2018-12-07 | 2020-06-11 | Bayer Aktiengesellschaft | Herbicidal compositions |
WO2020114934A1 (en) | 2018-12-07 | 2020-06-11 | Bayer Aktiengesellschaft | Herbicide compositions |
US11548859B2 (en) | 2018-12-21 | 2023-01-10 | Intervet Inc. | Method for producing (5,S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4Hisoxazol-3-yl]-2-methyl-benzoic acid |
WO2020127878A1 (en) * | 2018-12-21 | 2020-06-25 | Intervet International B.V. | Method for producing (5s)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4h-isoxazol-3-yl]-2-methyl-benzoic acid |
US11530187B2 (en) | 2018-12-21 | 2022-12-20 | Intervet Inc. | Method for producing (5S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-benzoic acid |
EP3696177A1 (en) | 2019-02-12 | 2020-08-19 | Basf Se | Heterocyclic compounds for the control of invertebrate pests |
WO2020164938A1 (en) | 2019-02-12 | 2020-08-20 | Basf Se | Heterocyclic compounds for the control of invertebrate pests |
EP3545764A1 (en) | 2019-02-12 | 2019-10-02 | Bayer AG | Crystal form of 2-({2-fluoro-4-methyl-5-[(r)-(2,2,2-trifluoroethyl)sulfinyl]phenyl}imino)-3-(2,2,2- trifluoroethyl)-1,3-thiazolidin-4-one |
WO2020173860A1 (en) | 2019-02-26 | 2020-09-03 | Bayer Aktiengesellschaft | Fused bicyclic heterocycle derivatives as pesticides |
WO2020173861A1 (en) | 2019-02-26 | 2020-09-03 | Bayer Aktiengesellschaft | Condensed bicyclic heterocyclic derivatives as pest control agents |
EP3564225A1 (en) | 2019-03-21 | 2019-11-06 | Bayer Aktiengesellschaft | Crystalline form of spiromesifen |
EP3725788A1 (en) | 2019-04-15 | 2020-10-21 | Bayer AG | Novel heteroaryl-substituted aminoalkyl azole compounds as pesticides |
WO2020212235A1 (en) | 2019-04-15 | 2020-10-22 | Bayer Animal Health Gmbh | Novel heteroaryl-substituted aminoalkyl azole compounds as pesticides |
WO2020225437A1 (en) | 2019-05-08 | 2020-11-12 | Bayer Aktiengesellschaft | Ulv formulations with enhanced uptake |
WO2020225435A1 (en) | 2019-05-08 | 2020-11-12 | Bayer Aktiengesellschaft | High spreading and uptake ulv formulations |
WO2020225440A1 (en) | 2019-05-08 | 2020-11-12 | Bayer Aktiengesellschaft | High spreading and rainfastness ulv formulations |
WO2020225428A1 (en) | 2019-05-08 | 2020-11-12 | Bayer Aktiengesellschaft | High spreading ulv formulations for insecticides |
WO2020225434A1 (en) | 2019-05-08 | 2020-11-12 | Bayer Aktiengesellschaft | High spreading ulv formulations for agrochemical compounds ii |
WO2020225439A1 (en) | 2019-05-08 | 2020-11-12 | Bayer Aktiengesellschaft | Ulv formulations with enhanced rainfastness |
WO2020225438A1 (en) | 2019-05-08 | 2020-11-12 | Bayer Aktiengesellschaft | High uptake and rainfastness ulv formulations |
WO2020225436A1 (en) | 2019-05-08 | 2020-11-12 | Bayer Aktiengesellschaft | High spreading, uptake and rainfastness ulv formulations |
WO2020225242A1 (en) | 2019-05-08 | 2020-11-12 | Bayer Aktiengesellschaft | Active compound combination |
WO2020229398A1 (en) | 2019-05-14 | 2020-11-19 | Bayer Aktiengesellschaft | (1-alkenyl)-substituted pyrazoles and triazoles as pest control agents |
EP3750888A1 (en) | 2019-06-12 | 2020-12-16 | Bayer Aktiengesellschaft | Crystalline form a of 1,4-dimethyl-2-[2-(pyridin-3-yl)-2h-indazol-5-yl]-1,2,4-triazolidine-3,5-dione |
WO2020263812A1 (en) | 2019-06-24 | 2020-12-30 | Auburn University | A bacillus strain and methods of its use for plant growth promotion |
EP3608311A1 (en) | 2019-06-28 | 2020-02-12 | Bayer AG | Crystalline form a of n-[4-chloro-3-[(1-cyanocyclopropyl)carbamoyl]phenyl]-2-methyl-4-methylsulfonyl-5-(1,1,2,2,2-pentafluoroethyl)pyrazole-3-carboxamide |
WO2021000865A1 (en) | 2019-07-01 | 2021-01-07 | 沈阳化工大学 | Isoxazoline compound, preparation method therefor and application thereof |
WO2021001273A1 (en) | 2019-07-04 | 2021-01-07 | Bayer Aktiengesellschaft | Herbicidal compositions |
EP3771714A1 (en) | 2019-07-30 | 2021-02-03 | Bayer AG | Nitrogen-containing heterocycles as pesticides |
EP3701796A1 (en) | 2019-08-08 | 2020-09-02 | Bayer AG | Active compound combinations |
WO2021058659A1 (en) | 2019-09-26 | 2021-04-01 | Bayer Aktiengesellschaft | Rnai-mediated pest control |
WO2021069575A1 (en) | 2019-10-11 | 2021-04-15 | Bayer Animal Health Gmbh | Heteroaryl-substituted pyrazine derivatives as pesticides |
WO2021089673A1 (en) | 2019-11-07 | 2021-05-14 | Bayer Aktiengesellschaft | Substituted sulfonyl amides for controlling animal pests |
WO2021097162A1 (en) | 2019-11-13 | 2021-05-20 | Bayer Cropscience Lp | Beneficial combinations with paenibacillus |
EP3845304A1 (en) | 2019-12-30 | 2021-07-07 | Bayer AG | Capsule suspension concentrates based on polyisocyanates and biodegradable amine based cross-linker |
WO2021136758A1 (en) | 2019-12-30 | 2021-07-08 | Bayer Aktiengesellschaft | Aqueous capsule suspension concentrates based on polyurea shell material containing polyfunctional aminocarboxylic esters |
WO2021165195A1 (en) | 2020-02-18 | 2021-08-26 | Bayer Aktiengesellschaft | Heteroaryl-triazole compounds as pesticides |
EP3868207A1 (en) | 2020-02-24 | 2021-08-25 | Bayer Aktiengesellschaft | Encapsulated pyrethroids with improved activity in soil and leaf applications |
WO2021170527A1 (en) | 2020-02-24 | 2021-09-02 | Bayer Aktiengesellschaft | Encapsulated pyrethroids with improved effictiveness in soil and leaf applications |
WO2021260017A1 (en) | 2020-06-26 | 2021-12-30 | Bayer Aktiengesellschaft | Aqueous capsule suspension concentrates comprising biodegradable ester groups |
WO2022022221A1 (en) * | 2020-07-30 | 2022-02-03 | 山东省联合农药工业有限公司 | Isoxazoline-substituted benzamide derivative, and preparation method therefor and use thereof |
EP3994985A1 (en) | 2020-11-08 | 2022-05-11 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift properties |
WO2022096694A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading and ulv tank mix adjuvant formulation |
EP3994995A1 (en) | 2020-11-08 | 2022-05-11 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading, high uptake and ulv tank mix adjuvant formulation |
WO2022096687A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift and uptake properties |
WO2022096695A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading, high uptake and ulv tank mix adjuvant formulation |
WO2022096690A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift, spreading and uptake properties |
WO2022096688A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift, spreading and rainfastness properties |
WO2022096693A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Low drift, rainfastness, high uptake and ulv tank mix adjuvant formulation |
WO2022096696A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading, high uptake and ulv tank mix adjuvant formulation |
WO2022096691A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift, uptake and rainfastness properties |
WO2022096686A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift properties |
WO2022096692A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift, spreading, uptake and rainfastness properties |
WO2022096685A1 (en) | 2020-11-08 | 2022-05-12 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift and spreading properties |
EP3994988A1 (en) | 2020-11-08 | 2022-05-11 | Bayer AG | Agrochemical composition with improved drift, spreading and rainfastness properties |
EP3994989A1 (en) | 2020-11-08 | 2022-05-11 | Bayer AG | Agrochemical composition with improved drift, rainfastness and uptake properties |
EP3994991A1 (en) | 2020-11-08 | 2022-05-11 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift, spreading, uptake and rainfastness properties |
EP3994994A1 (en) | 2020-11-08 | 2022-05-11 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading, high uptake and ulv tank mix adjuvant formulation |
EP3994990A1 (en) | 2020-11-08 | 2022-05-11 | Bayer AG | Agrochemical composition with improved drift, spreading and uptake properties |
EP3994986A1 (en) | 2020-11-08 | 2022-05-11 | Bayer Aktiengesellschaft | Agrochemical composition with improved drift and spreading properties |
EP3994992A1 (en) | 2020-11-08 | 2022-05-11 | Bayer AG | Low drift, rainfastness, high uptake and ulv tank mix adjuvant formulation |
EP3994987A1 (en) | 2020-11-08 | 2022-05-11 | Bayer AG | Agrochemical composition with improved drift and uptake properties |
EP3994993A1 (en) | 2020-11-08 | 2022-05-11 | Bayer Aktiengesellschaft | Low drift, rainfastness, high spreading and ulv tank mix adjuvant formulation |
WO2022152728A1 (en) | 2021-01-15 | 2022-07-21 | Bayer Aktiengesellschaft | Herbicidal compositions |
WO2022171472A1 (en) | 2021-02-11 | 2022-08-18 | Basf Se | Substituted isoxazoline derivatives |
EP4043444A1 (en) | 2021-02-11 | 2022-08-17 | Basf Se | Substituted isoxazoline derivatives |
WO2022207887A1 (en) | 2021-03-31 | 2022-10-06 | Syngenta Crop Protection Ag | Insect pest bait composition with isocycloseram and method for controlling insect pests |
WO2022238194A1 (en) | 2021-05-10 | 2022-11-17 | Bayer Aktiengesellschaft | Herbicide/safener combination based on safeners from the class of substituted [(1,5-diphenyl-1h-1,2,4-triazol-3-yl)oxy]acetic acids and their salts |
WO2022238575A1 (en) | 2021-05-14 | 2022-11-17 | Syngenta Crop Protection Ag | Insect, acarina and nematode pest control |
WO2022238576A1 (en) | 2021-05-14 | 2022-11-17 | Syngenta Crop Protection Ag | Seed treatment compositions |
WO2023031061A1 (en) | 2021-08-30 | 2023-03-09 | Syngenta Crop Protection Ag | Process for the preparation of an optically active isoxazoline compound |
EP4265110A1 (en) | 2022-04-20 | 2023-10-25 | Bayer AG | Water dispersible granules with low melting active ingredients prepared by extrusion |
WO2023203009A1 (en) | 2022-04-20 | 2023-10-26 | Bayer Aktiengesellschaft | Water dispersible granules with low melting active ingredients prepared by extrusion |
WO2023202966A1 (en) | 2022-04-21 | 2023-10-26 | Syngenta Crop Protection Ag | Pesticidal compositions including an isoxazoline compound |
WO2023217619A1 (en) | 2022-05-07 | 2023-11-16 | Bayer Aktiengesellschaft | Low drift aqueous liquid formulations for low, medium, and high spray volume application |
WO2023222724A1 (en) | 2022-05-16 | 2023-11-23 | Syngenta Crop Protection Ag | Method for mosquito control |
WO2023232560A1 (en) | 2022-05-30 | 2023-12-07 | Syngenta Crop Protection Ag | Process for the preparation of 4-substituted 2-oxazolidinones |
WO2024013015A1 (en) | 2022-07-11 | 2024-01-18 | Bayer Aktiengesellschaft | Herbicidal compositions |
WO2024013016A1 (en) | 2022-07-11 | 2024-01-18 | Bayer Aktiengesellschaft | Herbicidal compositions |
WO2024033374A1 (en) | 2022-08-11 | 2024-02-15 | Syngenta Crop Protection Ag | Novel arylcarboxamide or arylthioamide compounds |
WO2024068473A1 (en) | 2022-09-27 | 2024-04-04 | Bayer Aktiengesellschaft | Herbicide/safener combination based on safeners from the class of substituted [(1,5-diphenyl-1h-1,2,4-triazol-3-yl)oxy]acetic acids and their salts |
EP4353082A1 (en) | 2022-10-14 | 2024-04-17 | Bayer Aktiengesellschaft | Herbicidal compositions |
KR102559251B1 (en) * | 2023-05-19 | 2023-07-24 | 전준형 | Control method using composition for pest control |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11357231B2 (en) | Insecticidal compounds based on isoxazoline derivatives | |
US10155730B2 (en) | Isoxazoline derivatives as insecticides | |
US9714228B2 (en) | Dihydrofuran derivatives as insecticidal compounds | |
US20140206633A1 (en) | Process for the preparation of isoxazoline derivatives | |
TW201528952A (en) | Insecticidal compounds based on isoxazoline derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080054495.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10787393 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010787393 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2780522 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12012500937 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010326766 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4224/DELNP/2012 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 219912 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2012/006171 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13512820 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 20127014101 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012541480 Country of ref document: JP Ref document number: 12091196 Country of ref document: CO Ref document number: CR2012-000299 Country of ref document: CR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1201002546 Country of ref document: TH |
|
ENP | Entry into the national phase |
Ref document number: 2010326766 Country of ref document: AU Date of ref document: 20101201 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: A201207701 Country of ref document: UA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 201200826 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12770 Country of ref document: GE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012013085 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012013085 Country of ref document: BR Kind code of ref document: A2 Effective date: 20120531 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 243017 Country of ref document: IL |